Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3022250	p-ld	U/l (u/l)	46960	205292	0.04%
3022250	p-ld	— (—)	5039	8845	100.00%	Distribution not available
3022250	p-ld	U/l_______ (u/l)	1406	8567	0.00%
3022250	p-laktaattidehydrogenaasi	U/l_______ (u/l)	1016	3262	0.00%
3022250	p-ld	U/L (u/l)	777	1829	0.00%
3022250	laktaattidehydrogenaasi	U/l (u/l)	101	112	0.00%
3022250	p-laktaattidehydrogenaasi	— (—)	22	29	100.00%	Distribution not available
3022250	p-laktaattidehydrogenaasi	U/l (u/l)	9	10	0.00%	Distribution not available	Distribution not available
3022250	s-laktaattidehydrogenaasi,pitoisuus(s-ld-is)	U/l (u/l)	6	6	0.00%	Distribution not available	Distribution not available
3022250	laktaattidehydrogenaasi(4526p-ld)	U/l (u/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other systemic involvement of connective tissue (FG)

2708

12524

2.40

321.40

3.4

4.5

234.87

245.81

u/l

3.74

2556

11848

Symptoms and signs concerning food and fluid intake

1307

4377

3.63

320.09

3.6

3.9

226.50

240.39

u/l

3.62

1237

4127

Adjustment and management of implanted device

2176

9528

2.70

316.90

4.7

3.9

256.03

241.60

u/l

4.93

2104

8900

AV-block

2122

7703

2.74

316.28

3.7

4.5

258.95

243.61

u/l

4.36

2016

7233

Myelodysplastic syndrome

354

423

25.64

316.24

14.0

2.1

260.37

238.87

u/l

2.97

338

397

Pulmonary embolism

3301

16970

2.21

315.83

5.0

4.3

257.73

244.88

u/l

4.21

3179

15996

Constipation

8392

36961

1.63

313.29

4.1

4.6

237.01

244.99

u/l

4.64

7874

35200

Gastrointestinal diseases

4570

12266

1.97

313.22

4.8

4.0

238.82

242.70

u/l

0.64

4342

11715

Pulmonary heart disease

3301

17025

2.21

312.95

5.0

4.3

257.73

245.15

u/l

4.08

3179

16057

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1189

3847

3.85

312.14

4.6

2.3

233.62

234.76

u/l

0.11

1164

3558

Symptoms and signs involving the digestive system and abdomen

8898

28899

1.62

311.84

4.7

4.4

240.09

244.57

u/l

1.47

8463

27474

Reimbursement for rheumatic diseases

5317

31296

1.83

310.67

3.2

4.6

241.31

242.43

u/l

0.23

5075

29690

Diabetes, insulin treatment (Kela reimbursement)

9070

35525

1.60

310.22

3.8

4.7

236.33

245.57

u/l

7.11

8584

33778

L01XE Protein kinase inhibitors

901

2566

5.57

309.83

13.3

4.5

284.90

245.98

u/l

5.87

883

2430

Benign neoplasm of colon, rectum, anus and anal canal

6461

33989

1.74

308.47

4.2

4.5

237.47

246.37

u/l

3.07

6106

32247

Other disorders of white blood cells

1014

2340

7.13

307.65

8.8

3.9

248.97

245.04

u/l

0.21

980

2229

Insulin, intermediate and long-acting

5672

32189

1.86

307.65

3.8

4.5

235.78

245.65

u/l

6.47

5402

30548

Unspecified kidney failure

1758

5231

4.70

307.65

4.5

4.1

245.03

246.95

u/l

0.21

1702

4892

Continuous positive airway pressure

1937

5925

3.14

307.65

4.3

5.7

250.59

246.51

u/l

0.45

1825

5685

Renal failure

9095

23965

4.44

307.65

4.6

4.4

250.48

246.10

u/l

1.49

8740

22582

Ulcer of lower limb, not elsewhere classified

2023

8063

3.16

307.65

3.9

4.3

249.13

247.50

u/l

0.16

1925

7605

Dyspnoea

10172

37649

2.16

307.65

4.3

4.5

245.24

241.66

u/l

1.53

9661

35772

Chronic lymphocytic leukaemia

901

1079

32.00

307.65

17.6

2.0

230.54

235.03

u/l

0.63

881

1010

Malignant neoplasm of skin

5002

14803

2.56

307.65

5.9

2.3

243.82

234.89

u/l

2.92

4810

13727

Hypothyroidism (congenital or acquired)

1786

2149

5.09

307.65

5.3

2.0

228.79

218.11

u/l

2.70

1708

2038

Type 2 diabetes

8782

32155

1.67

307.65

3.9

4.7

236.90

244.13

u/l

4.58

8308

30585

Condition for Implicit Sepsis (Organ dysfunction codes)

10062

31599

2.49

307.65

4.7

4.3

250.70

239.06

u/l

8.33

9549

30004

Bacterial Sepsis

7439

22374

3.42

307.65

5.1

4.2

251.92

242.84

u/l

4.79

7089

21164

Heart failure,strict

7552

19812

3.27

307.65

5.0

4.7

260.20

240.86

u/l

17.56

7213

18745

Ischemic heart diseases

7924

26960

1.90

307.65

4.7

4.8

253.52

239.68

u/l

8.25

7586

25573

Cerebrovascular diseases (FINNGEN)

2804

7099

3.10

307.65

5.0

5.1

243.22

236.29

u/l

1.35

2693

6738

Presence of cardiac and vascular implants and grafts

5504

19651

2.38

307.65

4.9

4.3

265.29

244.66

u/l

17.03

5203

18642

Certain infectious and parasitic diseases

9374

23644

2.15

307.65

5.2

3.7

243.19

239.39

u/l

1.11

8938

22395

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

8451

31589

1.68

307.65

3.8

4.8

236.39

245.31

u/l

6.04

8002

30042

Persons encountering health services for other counselling and medical advice, not elsewhere classified

10540

34555

1.72

307.65

4.6

4.4

239.92

243.34

u/l

1.16

10126

32734

Persons encountering health services in other circumstances, wide

11156

34732

1.76

307.65

4.6

4.4

240.92

243.34

u/l

0.66

10670

32883

Non-rheumatic valve diseases

6150

16673

3.14

307.65

4.2

4.8

265.41

239.87

u/l

23.62

5862

15799

Examination and observation for other reasons

6212

15958

2.42

307.65

5.0

4.1

236.01

246.94

u/l

4.64

5951

15235

Diseases of liver

3943

18984

2.38

307.65

3.9

4.7

250.70

243.02

u/l

1.52

3738

18043

Anaemia in chronic diseases classified elsewhere

542

970

11.62

307.65

4.8

4.5

248.57

241.22

u/l

0.43

520

924

Preparatory care for dialysis

1111

2005

14.36

307.65

3.9

4.6

235.92

245.43

u/l

0.98

1106

1914

Erysipelas

6196

25860

2.31

307.65

4.3

4.0

247.96

240.90

u/l

2.86

5888

24403

Agranulocytosis

1804

5011

5.15

307.65

9.5

4.1

249.68

241.67

u/l

1.23

1762

4749

Acquired haemolytic anaemia

615

1026

15.39

307.65

18.2

3.8

372.16

257.42

u/l

11.34

595

976

Chronic lymphocytic leukaemia, helper endpoint

901

1079

32.00

307.65

17.6

2.0

230.54

235.03

u/l

0.63

881

1010

Anaemias

4095

2075

17.49

307.65

6.0

2.0

242.32

219.04

u/l

10.18

3936

1969

Care involving use of rehabilitation procedures

5682

29044

1.89

307.65

4.2

246.90

236.39

u/l

4.20

5457

27423

Calcific aortic valvular stenosis

4018

18080

2.57

307.65

3.5

4.2

269.05

247.30

u/l

15.55

3818

16988

Malignant neoplasm of respiratory system and intrathoracic organs

2633

7782

3.39

307.65

4.3

2.2

256.25

236.08

u/l

6.56

2562

7197

Hypertension

7065

20360

2.12

307.65

4.6

4.8

239.90

243.46

u/l

0.91

6762

19348

Diabetes mellitus

9130

33222

1.68

307.65

4.0

4.7

237.14

243.88

u/l

4.18

8656

31614

Hypothyroidism, levothyroxine purchases

1765

2141

5.05

307.65

5.2

2.0

228.82

218.10

u/l

2.69

1688

2030

Septicaemia

6614

20885

3.62

307.65

5.8

3.9

255.47

242.41

u/l

7.70

6346

19678

Malignant melanoma

2129

6107

4.52

307.65

8.0

2.2

239.16

234.74

u/l

0.44

2076

5656

Other special examinations and investigations of persons without complaint or reported diagnosis

5659

16107

1.89

307.65

4.7

4.1

236.02

246.94

u/l

5.91

5384

15358

Heart failure, not strict

10583

25551

3.39

307.65

5.0

4.7

254.99

239.48

u/l

12.05

10147

24238

Other medical care

7880

22201

3.77

307.65

6.3

4.0

276.44

237.88

u/l

33.64

7633

20876

Extracorporeal dialysis

1410

2844

10.43

307.65

4.8

4.5

248.90

244.08

u/l

0.49

1398

2711

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

10642

33558

2.20

307.65

5.8

4.1

248.28

238.78

u/l

5.26

10167

31935

Asthma

6546

17804

2.03

307.65

3.9

4.1

235.20

240.50

u/l

1.66

6248

16875

Diffuse large B-cell lymphoma, helper endpoint

1479

1788

30.40

307.65

8.5

2.4

320.55

231.94

u/l

13.25

1444

1668

Asthma (only as main-diagnosis)

5881

17804

1.97

307.65

3.7

4.1

235.83

240.50

u/l

1.27

5593

16875

Explicit bacterial Sepsis

1413

4907

3.60

307.65

5.8

4.2

251.11

241.38

u/l

1.45

1360

4639

Rare circulating lymphoid malignancy, including Hilmo

720

964

17.66

307.65

14.2

2.4

264.34

235.54

u/l

3.10

705

919

Viral pneumonia

1775

5734

3.91

307.65

6.4

4.1

257.24

240.21

u/l

4.63

1711

5409

Emergency coronary revascularization (for ACS)

8576

29512

1.91

307.65

4.7

254.69

241.01

u/l

9.39

8191

27951

10502

34558

1.63

307.65

5.0

4.1

239.01

243.38

u/l

2.00

9971

32811

Complications of medical and surgical care

7755

38919

1.96

307.65

5.3

4.3

245.45

241.94

u/l

1.06

7374

36958

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3604

9072

2.73

307.65

4.9

236.42

232.03

u/l

0.96

3454

8617

Malignant neoplasm of bronchus and lung

2170

6863

3.13

307.65

4.2

2.1

260.25

236.94

u/l

6.53

2110

6339

Basal cell carcinoma

3873

13505

2.13

307.65

4.9

2.2

246.45

235.60

u/l

4.21

3685

12499

ILD differential diagnosis

6969

17979

2.08

307.65

4.8

4.1

241.01

240.24

u/l

0.12

6659

17038

Explicit Sepsis, including avohilmo

6885

22641

3.40

307.65

5.8

4.2

255.23

242.04

u/l

8.03

6607

21413

Essential (haemorrhagic) thrombocythaemia

1148

1237

36.06

307.65

10.9

2.2

278.37

233.22

u/l

16.73

1121

1148

Basal cell carcinoma, including Hilmo

4020

13860

2.14

307.65

4.9

2.2

245.34

235.45

u/l

3.88

3827

12833

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6129

35249

1.85

307.65

5.4

4.3

244.88

242.32

u/l

0.61

5822

33452

Persons encountering health services for specific procedures and health care

12712

32518

2.59

307.65

5.3

4.1

255.60

234.16

u/l

23.60

12241

30735

Care involving dialysis

1996

3391

12.80

307.65

4.5

245.70

235.63

u/l

2.23

1980

3224

Implicit bacterial Sepsis

6571

20670

3.40

307.65

5.0

4.2

253.00

243.55

u/l

4.56

6255

19530

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

8304

34517

2.40

307.65

4.9

4.4

241.12

244.98

u/l

1.47

7944

32672

Hypertensive heart and/or renal disease

3077

9931

2.62

307.65

3.5

4.8

245.81

249.51

u/l

0.63

2917

9379

Diseases of arteries, arterioles and capillaries

7539

30408

2.02

307.65

3.8

4.6

249.04

244.19

u/l

1.58

7164

28813

Antihypertensive medication - note that there are other indications

4521

11834

2.12

307.65

4.6

4.8

233.73

234.29

u/l

0.08

4325

11315

Certain infectious and parasitic diseases, including avohilmo

6264

17298

1.93

307.65

4.9

3.8

240.79

242.76

u/l

0.33

5970

16374

Viral Sepsis

3026

10640

3.56

307.65

5.7

4.1

250.32

243.21

u/l

1.56

2887

10043

Other heart diseases, wide

9135

26397

2.29

307.65

5.0

4.6

248.34

235.62

u/l

10.03

8739

25121

Implicit viral Sepsis, including avohilmo

4067

16088

3.03

307.65

5.3

4.1

248.94

243.37

u/l

1.36

3880

15179

Metabolic disorders

9984

30643

2.14

307.65

4.6

4.5

244.02

243.19

u/l

0.16

9502

29110

Any event in cancer register

10447

23902

2.89

307.65

6.8

2.8

250.66

232.94

u/l

14.09

10111

22453

All chronic kidney diseases

9208

23599

3.97

307.65

4.4

4.5

244.47

245.05

u/l

0.12

8859

22316

Fever of other and unknown origin

8939

22475

4.27

307.65

6.9

3.8

251.16

240.43

u/l

5.68

8642

21276

Acute tubulo-interstitial nephritis

6864

28300

2.28

307.65

4.0

4.3

239.94

241.72

u/l

0.44

6503

26764

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

11956

35127

2.56

307.65

5.5

4.2

248.06

238.84

u/l

6.57

11475

33330

Liquid cancers

9991

11693

22.05

307.65

10.7

2.3

262.36

235.41

u/l

24.46

9772

10823

Excluding asthma or asthma-COPD overlap

7021

17965

2.10

307.65

4.8

4.1

240.68

240.57

u/l

0.02

6706

17026

Malignant neoplasm of digestive organs

3672

13205

2.36

307.65

3.7

2.3

251.37

235.79

u/l

2.99

3512

12231

ILD medications: immunosuppressive drugs

8412

28028

3.19

307.65

5.9

3.9

242.97

240.61

u/l

0.67

8129

26600

Thrombocytopenia, unspecified

1490

3390

7.59

307.65

8.0

4.1

270.67

245.99

u/l

3.70

1450

3212

Medical observation and evaluation for suspected diseases and conditions

6444

16102

2.22

307.65

5.2

4.1

235.95

246.94

u/l

5.42

6062

15355

Multiple myeloma, including Hilmo

1215

1669

19.67

307.65

12.8

2.0

227.13

233.74

u/l

1.05

1195

1547

Malignant melanoma of skin, including Hilmo

1866

5639

4.19

307.65

8.1

2.2

241.65

233.55

u/l

0.84

1819

5218

Symptoms and signs involving the urinary system

7625

34822

1.78

307.65

4.1

4.6

238.54

244.60

u/l

2.16

7174

33108

Malignant neoplasm, including Hilmo

10833

20793

3.54

307.65

7.0

2.4

251.62

232.97

u/l

15.25

10514

19426

Implicit Sepsis

9946

30421

2.80

307.65

4.7

4.3

249.74

240.51

u/l

5.51

9428

28854

Mantle cell lymphoma, including Hilmo

387

475

27.09

307.65

10.1

1.9

247.50

240.51

u/l

0.42

378

446

Hypertensive diseases (excluding secondary)

4523

9742

2.98

307.65

4.8

238.52

233.80

u/l

1.01

4350

9262

Lymphoid leukaemia

1468

2752

13.65

307.65

16.3

3.9

238.94

250.91

u/l

1.34

1435

2614

Diffuse large B-cell lymphoma

1479

1788

30.40

307.65

8.5

2.4

320.55

231.94

u/l

13.25

1444

1668

Infections, IBD-co-morbidities

2171

3632

5.19

307.65

7.7

5.2

248.09

253.09

u/l

0.42

2075

3494

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

18629

29486

5.65

307.65

5.4

3.9

246.91

239.15

u/l

5.59

17780

27987

Provisional assignment of new diseases of uncertain etiology

6940

29647

2.71

307.65

5.2

4.2

245.27

242.65

u/l

0.75

6725

28048

Other malignant neoplasms of skin (=non-melanoma skin cancer)

4013

13804

2.16

307.65

4.8

2.2

245.86

235.56

u/l

3.92

3821

12781

Codes for special purposes

6948

29676

2.71

307.65

5.3

4.2

245.27

242.62

u/l

0.76

6733

28073

Transplanted organ and tissue status

2281

3999

11.09

307.65

12.1

4.4

247.42

240.22

u/l

1.16

2262

3815

Implicit bacterial Sepsis, including avohilmo

7065

21912

3.31

307.65

4.8

4.2

251.58

243.22

u/l

3.96

6718

20723

ILD medications: azathioprine

1601

5454

3.48

307.65

4.2

4.0

244.14

236.78

u/l

1.04

1552

5170

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1226

3847

4.43

307.65

4.2

4.1

225.58

248.75

u/l

6.24

1158

3620

Asthma (mode)

6373

17979

1.99

307.65

3.8

4.1

236.22

240.24

u/l

1.07

6077

17038

Cardiovascular diseases

4778

10754

2.54

307.65

5.0

4.5

234.92

230.81

u/l

0.74

4576

10275

All-cause Heart Failure

8077

24118

2.80

307.65

4.6

4.5

259.55

242.47

u/l

15.16

7700

22824

GASTRO-related operations

7898

13037

3.37

307.65

5.2

3.0

241.91

236.67

u/l

1.26

7528

12292

Implicit viral Sepsis

3023

10628

3.56

307.65

5.7

4.1

249.95

243.24

u/l

1.44

2884

10032

Covid-19 confirmed case

5698

21268

3.35

307.65

5.4

4.1

248.88

245.99

u/l

0.71

5520

20051

Pneumonias (Asthma/COPD co-morbidities)

12322

34607

2.64

307.65

5.5

4.1

249.06

237.94

u/l

9.38

11837

32819

Insulin, combination of fast acting with intermediate-acting or long-acting

6322

34135

1.83

307.65

4.0

4.5

237.32

245.14

u/l

4.58

6029

32363

Complications of surgical and medical care, not elsewhere classified

10595

39008

1.97

307.65

5.1

4.2

244.29

241.42

u/l

1.01

10073

37045

Diffuse large B-cell lymphoma, including Hilmo

1479

1788

30.40

307.65

8.5

2.4

320.55

231.94

u/l

13.25

1444

1668

Asthma, unspecified (mode), excluding more controls

4998

14944

2.64

307.65

3.8

4.1

236.90

237.59

u/l

0.10

4759

14157

Nutritional anaemias

7784

27056

3.41

307.65

4.0

4.3

239.83

246.53

u/l

2.47

7310

25619

Explicit Sepsis

6762

22327

3.41

307.65

5.9

4.2

255.13

242.28

u/l

7.68

6488

21108

Malignant neoplasm of bronchus and lung, including Hilmo

2531

7816

3.23

307.65

4.3

2.2

259.44

236.38

u/l

7.24

2464

7230

Calcific aortic valvular stenosis, diagnosis (helper)

4010

18048

2.56

307.65

3.4

4.2

269.04

247.05

u/l

15.93

3810

16956

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

10082

31679

2.39

307.65

4.7

4.3

248.22

238.63

u/l

6.06

9599

30087

Autoimmune diseases excluding thyroid diseases, strict definition

10403

31162

1.96

307.65

4.2

4.4

240.16

242.86

u/l

0.82

9970

29556

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

901

1079

32.00

307.65

17.6

2.0

230.54

235.03

u/l

0.63

881

1010

Conduction disorders

3126

11924

2.36

307.65

3.9

4.7

251.92

242.02

u/l

3.30

2961

11260

Abnormal findings on examination of blood, without diagnosis

5708

26213

2.25

307.65

4.7

4.5

241.42

244.50

u/l

0.66

5490

24840

Malignant neoplasm of digestive organs, including Hilmo

4234

13852

2.52

307.65

3.8

2.3

251.17

235.78

u/l

3.52

4057

12838

Calcific aortic valvular stenosis, operated

4018

18080

2.57

307.65

3.5

4.2

269.05

247.30

u/l

15.55

3818

16988

DVT of lower extremities and pulmonary embolism

4521

24969

2.01

307.65

5.0

4.2

254.10

244.80

u/l

3.45

4328

23565

Any reimbursement code in KELA

4568

8522

2.90

307.65

5.4

2.5

238.12

224.44

u/l

5.20

4377

8019

Follicular lymphoma, hilmo

1158

2030

17.70

307.65

7.8

4.3

234.76

246.99

u/l

1.38

1131

1921

Bacterial infection, other or unspecified, including avohilmo

9986

25583

4.11

307.65

6.3

4.0

252.09

241.24

u/l

6.58

9598

24131

Atrial fibrillation and flutter

3162

6638

3.52

307.65

5.2

254.38

235.74

u/l

6.36

3036

6297

Diarrhoea and gastroenteritis of presumed infectious origin

6758

35841

1.80

307.65

4.7

4.2

238.60

243.01

u/l

1.63

6424

34066

Erysipelas, including avohilmo

7979

28212

2.33

307.65

4.2

4.0

245.54

239.48

u/l

2.82

7581

26659

Percutaneous Coronary Intervention

7853

26385

1.98

307.65

4.8

254.34

240.04

u/l

9.11

7506

25026

Acute myeloid leukaemia and myelodysplastic syndromes

619

790

19.96

307.65

18.5

2.0

303.00

235.32

u/l

6.29

600

738

Major coronary heart disease event

8152

28285

1.87

307.65

4.8

4.7

254.18

240.04

u/l

9.09

7780

26813

Atrial fibrillation and flutter with reimbursement

2598

5551

3.40

307.65

4.8

5.3

244.35

237.88

u/l

1.20

2495

5258

Complications of procedures, not elsewhere classified

8206

38003

1.88

307.65

4.5

4.2

245.55

241.67

u/l

1.22

7815

36101

Myeloid leukaemia

671

1182

13.94

307.65

20.0

4.2

296.25

250.37

u/l

2.77

661

1115

First line medication for Crohn's disease

13239

29599

2.71

307.65

5.5

3.7

245.28

238.27

u/l

3.89

12719

27981

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

3012

8629

3.50

307.65

4.4

2.2

256.19

235.41

u/l

7.58

2933

7987

Heart failure, strict

8241

24412

2.83

307.65

4.8

4.5

259.79

242.43

u/l

15.97

7857

23109

Secondary hypertension

1270

2347

7.52

307.65

3.6

4.8

233.35

239.66

u/l

0.64

1237

2231

Inflammatory bowel disease treatment related agents

12835

34824

2.26

307.65

5.1

4.2

244.29

240.13

u/l

1.68

12282

33033

Hypertension, essential

7025

19954

2.16

307.65

4.2

4.8

239.38

242.49

u/l

0.76

6714

18951

Heart failure and antihypertensive medication

3571

5866

5.06

307.65

6.3

5.8

263.64

245.48

u/l

5.30

3453

5574

Solid cancers

9077

20322

2.96

307.65

5.7

2.4

250.60

232.55

u/l

12.48

8773

18970

Syncope and collapse

4417

18445

2.19

307.65

4.0

3.8

239.99

242.54

u/l

0.52

4136

17428

Multiple myeloma

749

993

20.65

307.65

13.5

2.0

223.75

235.11

u/l

2.51

735

917

Neoplasms

7236

14817

2.81

307.65

5.9

2.5

244.09

232.34

u/l

4.53

6986

13922

Operations 2 for CAVS

4010

18048

2.56

307.65

3.4

4.2

269.04

247.05

u/l

15.93

3810

16956

Acute renal failure

4115

12024

4.88

307.65

5.3

4.3

261.80

246.33

u/l

4.92

3947

11305

Myelodysplastic syndrome, including Hilmo

780

1080

17.94

307.65

13.3

2.0

255.85

234.73

u/l

4.07

752

995

Pain in throat and chest

7716

25785

1.89

307.65

4.2

4.5

238.35

240.79

u/l

0.57

7324

24531

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2365

7614

3.88

307.65

4.9

2.3

268.77

234.58

u/l

10.80

2303

7059

Malignant melanoma of skin

1613

4607

4.54

307.65

8.5

2.2

241.04

232.75

u/l

0.75

1576

4258

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

3573

6007

10.89

307.65

7.6

2.3

260.72

232.84

u/l

15.33

3486

5570

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2735

5131

2.86

307.65

4.9

4.0

240.55

240.44

u/l

0.01

2613

4871

Implicit Sepsis, including avohilmo

10192

31570

2.63

307.65

4.7

4.3

250.43

239.48

u/l

7.44

9664

29967

Headache

5503

22814

1.99

307.65

4.2

3.8

235.01

239.17

u/l

0.85

5200

21644

Non-invasive ventilation

2468

7669

3.14

307.65

4.0

5.5

245.57

242.18

u/l

0.50

2322

7368

Non-small cell lung cancer

1340

4252

3.87

307.65

4.4

2.1

244.02

235.26

u/l

1.49

1313

3904

Finngen Rheumatological endpoints

8425

29902

1.69

307.65

4.4

4.6

237.11

241.87

u/l

1.71

8006

28472

Heart failure and coronary heart disease

5720

17994

2.66

307.65

5.1

4.6

263.84

241.78

u/l

19.17

5450

16961

Symptoms and signs involving the circulatory and respiratory systems

8722

26274

1.76

307.65

4.4

239.58

240.83

u/l

0.25

8310

25010

Hypothyroidism, drug reimbursement

904

1252

5.54

307.65

4.6

1.9

232.52

217.53

u/l

2.95

860

1173

Haemorrhage from respiratory passages

3956

16928

2.33

307.65

4.7

4.5

256.88

244.30

u/l

3.61

3739

16030

Diverticular disease of intestine

7130

25870

1.86

307.65

4.4

4.5

236.53

248.16

u/l

7.66

6755

24587

Calcific aortic valvular stenosis, including rheumatic fever

4018

18102

2.56

307.65

3.4

4.2

269.73

246.89

u/l

16.64

3818

17006

Pain, not elsewhere classified

2738

11780

2.60

307.65

4.2

3.9

234.59

240.40

u/l

1.27

2611

11149

ILD medications: prednisolone, methylprednisolone, prednisone

12935

31296

2.58

307.65

5.3

3.8

245.34

240.07

u/l

2.43

12395

29636

Other diseases of the digestive system

3730

19423

2.18

307.65

4.4

4.3

245.04

248.26

u/l

0.59

3526

18324

Enlarged lymph nodes

3243

6295

7.90

307.65

7.2

4.1

244.08

241.01

u/l

0.35

3166

5959

Nausea and vomiting

3066

13489

2.52

307.65

5.0

4.3

241.58

247.20

u/l

1.05

2920

12725

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1273

2705

3.96

307.65

5.1

5.4

259.42

261.04

u/l

0.09

1223

2596

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1002

1972

11.59

307.65

8.7

4.2

284.70

247.44

u/l

4.15

977

1866

Pneumonia, organism unspecified

11289

32700

2.70

307.65

5.5

4.1

248.01

238.74

u/l

6.15

10838

31004

L04AD Calcineurin inhibitors

2173

4486

8.13

307.65

9.2

4.6

250.17

245.17

u/l

0.61

2148

4290

COPD/asthma related infections

9698

26418

1.98

307.65

5.1

4.0

243.10

239.55

u/l

1.17

9254

25062

Valvular operations

2292

6587

4.75

307.65

3.5

4.6

294.65

242.61

u/l

28.99

2210

6220

Non-Hodgkin lymphoma, all

1201

1666

18.26

307.65

10.1

2.0

335.91

233.99

u/l

11.64

1179

1540

Oxycodone

6391

17858

3.88

307.65

6.1

4.3

261.57

245.46

u/l

7.81

6125

16941

L04AA Selective immunosuppressants

3098

10244

3.84

307.65

5.5

4.7

247.32

240.94

u/l

1.60

3021

9742

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

3735

9922

4.89

307.65

6.1

2.2

279.16

234.47

u/l

25.96

3645

9205

Other diseases of blood and blood-forming organs

1504

3104

8.99

307.65

8.3

4.1

258.76

242.44

u/l

2.92

1446

2940

L01XX Other antineoplastic agents

1779

2898

23.23

307.65

15.4

3.7

280.49

246.58

u/l

10.07

1740

2734

Autoimmune diseases related-to ILD

8110

41327

1.75

307.65

3.9

4.5

234.30

242.24

u/l

5.81

7730

39267

Malignant neoplasm

10791

20575

3.61

307.65

7.1

2.4

251.95

233.02

u/l

15.80

10471

19218

GI-bleeding

3703

19461

2.15

307.65

4.4

4.3

245.00

248.34

u/l

0.62

3511

18351

Iron deficiency anaemia secondary to blood loss (chronic)

2291

7915

3.68

307.65

5.2

4.3

246.33

249.46

u/l

0.34

2173

7475

Iron deficiency anaemia

7017

23442

3.75

307.65

4.0

4.3

236.15

246.32

u/l

6.01

6585

22188

Other and unspecified anaemias

9421

22331

5.97

307.65

4.7

4.2

246.93

246.47

u/l

0.08

8950

21089

Dental caries

3703

11821

3.66

307.65

7.2

4.3

242.04

250.47

u/l

1.93

3566

11258

Azathioprine

1601

5840

3.23

307.65

4.2

4.5

244.14

236.10

u/l

1.21

1552

5542

Parasetamol

6305

16874

2.01

307.65

4.6

4.4

234.69

245.83

u/l

4.70

5981

16128

COPD (mode)

3208

11511

2.45

307.65

3.5

4.2

237.81

245.24

u/l

1.82

3033

10840

Hypo-osmolality and hyponatraemia

2244

9042

2.97

307.65

4.0

4.4

244.55

247.67

u/l

0.30

2114

8537

Secondary and unspecified malignant neoplasm of lymph nodes

2497

2999

23.57

307.65

8.3

2.4

260.17

232.36

u/l

11.65

2437

2794

Pulmonary heart disease, diseases of pulmonary circulation

3648

18678

2.23

307.65

5.2

4.2

259.62

245.25

u/l

5.60

3517

17606

STROKE

4943

18039

2.00

307.65

5.0

244.48

240.56

u/l

0.89

4706

17128

Disorders resulting from impaired renal tubular function

747

1616

8.60

307.65

3.4

4.7

234.10

254.13

u/l

2.10

735

1533

Purpura and other haemorrhagic conditions

2342

6538

5.15

307.65

7.6

4.3

264.98

240.78

u/l

6.37

2279

6201

Coronary revascularization (ANGIO or CABG)

7801

26397

1.96

307.65

4.8

254.38

240.04

u/l

9.12

7454

25038

Abnormal findings on diagnostic imaging of lung

6151

28068

2.41

307.65

5.0

4.3

242.57

246.48

u/l

1.19

5905

26540

Abnormalities of breathing

8880

26239

2.10

307.65

4.4

4.5

241.83

240.87

u/l

0.22

8449

24977

Other CVD (FINNGEN)

1361

3105

4.07

307.65

4.0

5.1

234.84

240.86

u/l

0.73

1277

2940

General examination and investigation of persons without complaint and reported diagnosis

5533

16073

1.90

307.65

5.2

4.1

238.59

246.92

u/l

3.18

5217

15331

Symptoms and signs involving the skin and subcutaneous tissue

6991

40158

1.77

307.65

5.2

4.3

234.74

243.40

u/l

5.46

6654

38175

Hypertensive diseases

7075

20369

2.12

307.65

4.7

4.8

239.92

243.46

u/l

0.90

6772

19357

General symptoms and signs

11588

25039

2.57

307.65

5.3

3.8

242.16

239.62

u/l

0.66

11085

23737

Hypothyroidism and >3 levothyroxin purchases

1765

2141

5.05

307.65

5.2

2.0

228.82

218.10

u/l

2.69

1688

2030

Myeloproliferative diseases

2379

4006

16.89

307.65

11.4

3.9

282.16

245.82

u/l

13.48

2326

3766

Other disorders of skin and subcutaneous tissue

7434

37205

1.83

307.65

4.5

4.4

240.85

243.44

u/l

0.68

7054

35306

Gout

4000

14132

2.96

307.65

6.0

4.7

247.00

248.27

u/l

0.18

3830

13406

Second line medication for Crohn's disease

6226

30859

2.26

307.65

4.9

4.5

241.37

242.11

u/l

0.14

5982

29369

Glomerular diseases

2785

9134

4.08

307.65

4.3

4.6

240.94

242.89

u/l

0.29

2711

8649

Type 2 diabetes, wide definition

8128

28363

1.97

307.65

3.9

4.9

236.06

247.34

u/l

9.18

7705

26969

Venous thromboembolism

5706

31676

1.91

307.65

5.1

4.3

253.22

243.53

u/l

4.41

5460

29941

Lung cancer and mesothelioma

2646

8031

3.45

307.65

4.3

4.1

254.69

247.62

u/l

0.94

2580

7557

Used for control exclusion in common control thyroid runs

9805

29916

1.75

307.65

4.5

4.4

238.15

243.15

u/l

2.22

9356

28384

Kidney transplant status

1158

2081

11.10

307.65

4.2

5.0

241.83

251.11

u/l

0.86

1152

1992

L04AX Other immunosuppressants

6074

30050

2.27

307.65

4.9

4.5

241.80

242.17

u/l

0.06

5835

28590

Secondary uncertain malignant neoplasm

3135

5182

11.01

307.65

7.5

2.2

268.60

233.41

u/l

16.51

3051

4780

Malignant neoplasm of urinary organs, including Hilmo

1368

4509

3.76

307.65

4.6

2.2

233.57

234.02

u/l

0.05

1334

4155

Primary_lymphoid and hematopoietic malignant neoplasms

7653

12322

16.66

307.65

10.9

3.2

257.97

241.42

u/l

6.75

7497

11569

Malignant neoplasm of skin, including Hilmo

5213

15325

2.55

307.65

5.9

2.3

243.23

234.79

u/l

2.79

5012

14227

Malignant neoplasm of testis, including Hilmo

420

488

18.41

307.65

7.2

2.5

249.14

233.16

u/l

0.71

415

460

Solid cancers, including Hilmo

9286

20708

2.95

307.65

5.5

2.4

250.47

232.70

u/l

12.30

8977

19345

Gout, FINNGEN

4000

17983

2.66

307.65

6.0

4.3

247.00

246.43

u/l

0.08

3830

16994

Disorders of lipoprotein metabolism and other lipidaemias

8028

28030

1.88

307.65

4.1

4.6

240.82

244.27

u/l

1.04

7633

26604

Pain in limb

8124

30299

1.83

307.65

4.4

4.6

236.83

244.33

u/l

3.92

7715

28855

Bleeding

8949

34689

1.99

307.65

4.7

4.5

250.28

242.68

u/l

3.45

8497

32939

Streptococcal septicaemia

1251

4059

3.99

307.65

5.7

3.9

252.37

239.78

u/l

2.10

1206

3815

COPD differential diagnosis

6974

17982

2.09

307.65

4.8

4.1

241.02

240.25

u/l

0.12

6664

17040

10868

26418

2.73

307.65

5.4

4.0

248.20

239.55

u/l

5.11

10437

25062

Tramadol

8316

23407

2.36

307.65

4.3

237.91

240.80

u/l

0.82

7925

22244

Any death

8071

26011

2.55

307.65

5.6

4.4

292.50

228.97

u/l

73.34

7728

24707

Malaise and fatigue

6667

19669

3.10

307.65

4.2

3.8

240.86

241.71

u/l

0.14

6322

18589

All kidney diseases

12712

33949

2.89

307.65

4.7

4.4

245.68

239.92

u/l

3.06

12175

32207

Codeine

8690

24976

2.02

307.65

4.1

4.2

233.57

238.90

u/l

2.53

8230

23764

Codeine or tramadol medication

10613

36218

1.69

307.65

4.1

4.5

234.74

242.94

u/l

6.73

10046

34479

Oral corticosteroids

12327

34167

2.35

307.65

5.1

4.2

245.48

240.30

u/l

2.36

11785

32402

Other disorders of fluid, electrolyte and acid-base balance

4327

16427

2.99

307.65

4.0

4.5

246.92

247.96

u/l

0.13

4080

15535

Oedema, not elsewhere classified

3903

15038

2.95

307.65

4.5

3.8

241.89

243.76

u/l

0.37

3704

14197

Pure hypercholesterolaemia

7351

27013

1.87

307.65

4.0

4.6

242.52

244.76

u/l

0.49

6973

25644

Other and unspecified diseases of blood and blood-forming organs

594

1088

11.52

307.65

8.7

4.0

250.76

247.28

u/l

0.14

586

1024

All pneumoniae

12337

34746

2.61

307.65

5.5

4.1

249.08

238.02

u/l

9.28

11853

32953

Insulin medication

6317

29217

1.97

307.65

4.0

4.8

237.28

247.56

u/l

7.03

6025

27781

Non-ischemic cardiomyopathy

4144

13601

2.92

307.65

4.8

4.7

259.08

242.80

u/l

6.51

3952

12845

Valvular heart disease excluding rheumatic fever

6204

16764

3.15

307.65

4.2

4.8

265.79

240.29

u/l

23.51

5916

15887

Other diseases of pleura

6144

24280

2.61

307.65

4.2

4.4

247.51

246.61

u/l

0.17

5911

22907

Polyarthropathies

7812

23413

2.40

307.65

4.6

4.7

242.67

244.56

u/l

0.41

7469

22293

Polycythaemia vera

912

1153

22.74

307.65

11.9

2.1

291.07

234.21

u/l

19.86

899

1084

Caries of dentine

3318

10618

3.77

307.65

7.1

4.3

240.39

250.22

u/l

2.30

3189

10113

ILD medications

13269

31638

2.53

307.65

5.5

3.8

243.94

240.18

u/l

1.43

12722

29970

Bronchitis

10152

39822

1.61

307.65

5.2

4.1

238.21

242.56

u/l

2.10

9669

37801

Bacterial pneumoniae

4224

19173

2.14

307.65

5.1

4.0

246.69

241.61

u/l

1.34

4045

18093

Other pulmonary diagnosis

6989

17965

2.09

307.65

4.8

4.1

241.06

240.57

u/l

0.08

6677

17026

Bacterial pneumonia, not elsewhere classified

4023

18226

2.15

307.65

5.0

4.0

247.20

241.68

u/l

1.45

3854

17200

Other bacterial diseases, including avohilmo

13291

31769

3.02

307.65

5.7

3.9

251.77

238.15

u/l

12.91

12759

30070

Other soft tissue disorders, not elsewhere classified

9009

30732

1.78

307.65

4.3

4.6

236.78

244.24

u/l

3.87

8547

29267

Heart failure and bmi 25plus

4405

12473

2.82

307.65

4.5

4.4

256.46

242.15

u/l

6.36

4179

11732

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

10868

26418

2.73

307.65

5.4

4.0

248.20

239.55

u/l

5.11

10437

25062

Renal tubulo-interstitial diseases

12427

33659

3.22

307.65

4.7

4.4

246.77

240.48

u/l

3.58

11900

31907

Other heart diseases

4925

9999

3.65

307.65

5.4

4.8

251.18

233.92

u/l

8.52

4752

9512

Cardiac arrhythmias

5166

15317

2.34

307.65

4.9

243.18

234.98

u/l

3.15

4929

14642

Hard cardiovascular diseases

7933

26169

1.94

307.65

4.8

252.07

239.60

u/l

6.74

7592

24843

COPD/asthma/ILD related infections

9698

26418

1.98

307.65

5.1

4.0

243.10

239.55

u/l

1.17

9254

25062

Other bacterial diseases

13460

32087

3.30

307.65

5.8

4.0

252.62

239.17

u/l

12.80

12926

30362

Other diseases of intestines

9678

32770

1.75

307.65

4.6

4.5

234.64

244.57

u/l

7.10

9167

31228

Influenza and pneumonia

12571

34057

2.56

307.65

5.6

4.0

248.39

237.69

u/l

8.83

12075

32299

Autoimmune diseases

10492

32188

1.76

307.65

4.4

4.5

237.79

242.64

u/l

2.31

10027

30538

Malignant neoplasm, wide definition

10778

21005

3.48

307.65

7.0

2.4

251.72

232.99

u/l

15.29

10461

19628

Autoimmune diseases excluding thyroid diseases

10764

32065

1.97

307.65

4.2

4.5

239.84

242.63

u/l

0.90

10310

30421

Bacterial infection, other or unspecified

9430

24402

4.26

307.65

6.4

3.9

253.22

241.66

u/l

6.80

9062

23007

Diseases of oesophagus, stomach and duodenum

10687

36116

1.88

307.65

4.0

4.6

236.99

244.11

u/l

3.48

10091

34432

Cardiovascular diseases (excluding rheumatic etc)

5320

12395

2.67

307.65

5.0

4.5

238.32

230.49

u/l

2.02

5114

11815

Osteopathies and chondropathies

5813

29658

1.97

307.65

4.7

4.4

238.88

243.74

u/l

2.05

5506

28130

Opioids

9259

25211

2.04

307.65

4.6

4.2

238.22

238.75

u/l

0.11

8816

23979

Asthma (only as main-diagnosis), excluding more controls

5629

15637

2.13

307.65

3.8

4.1

235.62

237.12

u/l

0.26

5361

14827

Systemic connective tissue disorders

3950

18972

2.38

307.65

3.7

4.4

238.29

245.33

u/l

2.48

3754

17941

Diabetic nephropathy, excluding more controls

2000

6638

3.08

307.65

3.3

4.1

237.37

238.82

u/l

0.22

1934

6262

Asthma, excluding more controls

6210

15637

2.19

307.65

3.9

4.1

234.95

237.12

u/l

0.43

5933

14827

Nephropathy related operations

2744

5985

8.52

307.65

6.6

4.6

257.19

243.85

u/l

3.18

2716

5693

Certain disorders involving the immune mechanism

2172

9039

2.86

307.65

6.1

4.6

238.51

241.02

u/l

0.33

2093

8614

Diseases of the digestive system

5100

27533

2.05

307.65

4.2

4.3

240.42

246.19

u/l

1.95

4840

26041

Dialysis, with operation codes

2929

5781

9.60

307.65

6.5

4.6

258.65

242.46

u/l

4.07

2897

5482

Other and unspecified disorders of white blood cells

797

1664

8.54

307.65

10.0

4.0

248.20

245.66

u/l

0.11

770

1573

Aplastic and other anaemias

10091

23525

5.86

307.65

4.8

4.2

247.78

246.32

u/l

0.32

9586

22228

Intestinal infectious diseases

9101

41902

1.72

307.65

4.9

4.3

238.81

242.65

u/l

1.56

8636

39844

Haemolytic anaemias

799

1451

11.52

307.65

16.1

3.7

339.59

252.93

u/l

10.60

773

1379

Coagulation defects, purpura and other haemorrhagic conditions

3065

9610

4.24

307.65

7.0

4.3

259.54

239.29

u/l

6.78

2973

9103

Other diseases of blood and blood-forming organs, wide

4493

10957

6.44

307.65

8.8

4.1

255.98

240.05

u/l

7.21

4357

10355

Dipeptidyl peptidase 4 (DPP-4) inhibitors

5830

27048

1.86

307.65

3.6

4.8

235.23

249.70

u/l

10.84

5480

25702

Other septicaemia, including avohilmo

5999

19662

3.59

307.65

5.9

3.8

256.47

242.52

u/l

7.63

5755

18519

Glomerular disorders in diseases classified elsewhere

2040

5774

5.21

307.65

4.1

4.6

240.61

241.99

u/l

0.16

1993

5479

Diabetes, varying definitions

9090

33228

1.68

307.65

4.0

4.7

237.41

243.86

u/l

3.85

8619

31619

Other and unspecified iron deficiency

5710

18361

4.05

307.65

3.5

4.3

230.58

246.52

u/l

13.01

5345

17383

Marginal zone B-cell lymphoma, including Hilmo

455

495

33.55

307.65

7.7

2.2

239.72

239.15

u/l

0.02

449

467

Depression medications

1781

2242

4.29

307.65

4.0

2.0

220.93

216.46

u/l

0.78

1696

2129

Malignant neoplasm

10764

20674

3.58

307.65

7.1

2.4

252.01

232.98

u/l

15.93

10447

19311

Other anaemias

9466

22447

5.93

307.65

4.7

4.2

247.06

246.36

u/l

0.13

8992

21202

Hodgkin lymphoma, hilmo

682

1088

14.40

307.65

7.7

4.6

230.64

245.86

u/l

1.76

665

1040

Liquid cancers, including Hilmo

11213

13245

16.98

307.65

10.2

2.2

262.00

235.43

u/l

26.30

10961

12270

Non-small cell lung cancer, including Hilmo

1885

5966

3.63

307.65

4.5

2.1

243.35

236.30

u/l

1.44

1841

5499

Malignant melanoma, including Hilmo

2307

6916

4.24

307.65

7.7

2.2

240.52

234.56

u/l

0.70

2244

6403

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1142

1773

14.03

307.65

6.3

2.0

226.42

233.22

u/l

1.23

1098

1645

Other pleural conditions

1652

5372

4.23

307.65

4.2

244.06

246.62

u/l

0.28

1603

5053

Multiple myeloma and malignant plasma cell neoplasms

1250

2446

13.06

307.65

12.6

3.8

226.76

248.90

u/l

4.51

1229

2300

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

749

993

20.65

307.65

13.5

2.0

223.75

235.11

u/l

2.51

735

917

Non-follicular lymphoma

2772

4843

16.55

307.65

8.7

4.2

286.15

240.42

u/l

10.46

2714

4580

Non-Hodgkin lymphoma, all, including Hilmo

4086

5029

23.88

307.65

8.5

2.2

270.88

233.99

u/l

13.52

3998

4643

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

4141

14190

2.15

307.65

4.8

2.2

244.19

235.52

u/l

3.18

3946

13148

Endocrine, nutritional and metabolic diseases

6525

18539

1.88

307.65

4.7

4.6

236.65

243.29

u/l

1.91

6211

17691

Other septicaemia

5891

19323

3.61

307.65

5.9

3.8

256.21

242.76

u/l

7.17

5649

18200

Myeloproliferative diseases (CML excluded)

2122

3627

16.32

307.65

11.1

3.9

284.95

244.99

u/l

15.02

2072

3421

Pleural effusion

2881

8527

4.95

307.65

4.3

236.58

246.82

u/l

2.87

2818

8016

Explicit bacterial Sepsis, including avohilmo

1450

5031

3.60

307.65

5.8

4.2

251.02

241.11

u/l

1.54

1396

4756

Chronic kidney disease

6400

17630

5.05

307.65

4.4

4.2

242.87

248.35

u/l

1.92

6174

16581

Streptococcal septicaemia, including avohilmo

1285

4160

4.01

307.65

5.6

3.9

252.33

239.66

u/l

2.18

1239

3911

Hernia of abdominal wall, postoperative

1920

5696

3.90

307.65

4.3

3.1

235.46

242.51

u/l

0.97

1826

5365

Any gastric operation

7898

13037

3.37

307.65

5.2

3.0

241.91

236.67

u/l

1.26

7528

12292

Asthma, unspecified (mode)

5199

17054

2.41

307.65

3.8

4.1

237.22

240.64

u/l

0.77

4944

16150

Other arrhythmias

5363

22842

1.87

307.65

4.4

4.6

240.00

236.03

u/l

1.18

5080

21707

All influenza

2763

12566

2.49

307.65

6.0

4.1

242.51

240.74

u/l

0.25

2621

11850

Diseases of arteries, arterioles and capillaries (FINNGEN)

2962

5561

4.46

307.65

3.9

5.3

249.77

236.81

u/l

2.99

2846

5275

Infections of the skin and subcutaneous tissue

5543

32786

1.79

304.23

4.9

4.5

238.78

242.46

u/l

1.01

5298

31250

Other bacterial intestinal infections

2120

9331

2.66

303.10

6.1

4.2

245.33

244.09

u/l

0.13

2006

8810

Factors influencing health status and contact with health services

2423

5124

2.55

302.76

4.5

3.8

246.32

236.59

u/l

1.38

2305

4855

Gout, idiopatic and unspecified

3060

15710

2.28

300.89

4.4

240.79

246.71

u/l

1.46

2911

14874

Bacterial pneumonia (organism specified)

4640

24196

1.90

298.82

5.5

4.2

248.44

245.32

u/l

0.72

4448

22822

Diseases of the skin and subcutaneous tissue

8631

28136

1.62

298.68

4.8

4.2

239.26

243.43

u/l

1.37

8173

26748

Other abnormal findings of blood chemistry

786

2048

5.67

298.09

5.2

4.3

234.21

245.60

u/l

1.13

773

1948

Malignant neoplasm of urinary organs

1156

3784

3.79

297.48

4.7

2.3

233.49

233.55

u/l

0.01

1129

3496

Coronary atherosclerosis

6044

23203

1.77

296.04

4.5

4.8

250.32

240.11

u/l

4.34

5738

21966

Hypertensive Heart Disease

2632

9463

2.40

294.59

3.5

4.8

247.16

249.46

u/l

0.31

2478

8929

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1858

7921

2.88

293.10

3.6

4.8

248.17

243.43

u/l

0.45

1773

7530

Gout, unspecified

2556

12456

2.44

291.23

4.5

4.3

241.09

246.30

u/l

1.03

2436

11770

Insulin, fast-acting

3641

19743

2.04

291.18

3.8

4.6

238.42

244.70

u/l

2.32

3490

18717

Persons encountering health services in other circumstances

3864

20991

1.98

291.15

4.1

4.4

238.14

242.76

u/l

0.98

3669

19895

Endocarditis

624

1384

6.97

291.00

3.8

4.6

281.69

237.30

u/l

6.76

606

1317

Disorders of mineral metabolism

1129

3723

3.87

290.59

4.8

4.7

254.36

243.59

u/l

1.36

1075

3562

Asthma, hospital admissions 3, pneumonia

3873

21372

2.00

290.25

4.3

4.4

243.75

247.61

u/l

0.82

3701

20162

Asthma-related pneumonia or sepsis

3873

21372

2.00

290.25

4.3

4.4

243.75

247.61

u/l

0.82

3701

20162

Intestinal infectious diseases, including avohilmo, including avohilmo

10362

39470

1.53

289.57

4.7

4.3

237.38

243.66

u/l

3.83

9832

37530

Asthma-related pneumonia

3865

21331

2.00

289.55

4.3

4.4

243.62

247.60

u/l

0.86

3693

20122

Diabetes medication

9112

35580

1.57

287.17

3.8

4.7

235.08

244.62

u/l

7.66

8628

33864

Bacterial intestinal infections, IBD co-morbidities

2128

9636

2.58

285.21

6.1

4.2

244.85

243.62

u/l

0.13

2016

9116

Viral pneumonia (unknown virus, not influenza)

962

2939

4.34

282.80

6.1

4.4

264.24

246.25

u/l

2.64

943

2792

Paroxysmal tachycardia

1815

6164

2.69

280.74

6.3

5.1

247.97

235.42

u/l

2.86

1726

5843

Other/unspecified cytomegaloviral diseases

430

724

12.58

280.55

13.6

5.2

277.98

241.58

u/l

3.85

423

695

Dermatitis

5928

36210

1.71

280.02

4.9

4.4

239.20

243.02

u/l

1.13

5653

34423

Cytomegalovirus infection, IBD co-morbidity

471

863

10.53

280.01

13.4

4.9

275.48

245.35

u/l

3.11

462

829

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

836

2329

4.68

279.07

5.4

2.4

262.24

232.48

u/l

1.94

816

2160

Pacemaker

4107

21879

1.96

277.67

4.7

4.2

261.23

246.56

u/l

8.44

3900

20615

Asthma-related infections

5602

33729

1.73

276.01

4.0

4.5

237.20

244.23

u/l

3.32

5336

32004

Asthma, hospital admission 2, infections

5602

33729

1.73

276.01

4.0

4.5

237.20

244.23

u/l

3.32

5336

32004

Idiopathic thrombocytopenic purpura

560

1210

7.78

273.87

8.1

4.0

255.15

254.34

u/l

0.02

548

1154

Ischaemic heart disease, wide definition

7035

27839

1.66

273.48

4.4

4.8

250.08

241.83

u/l

2.97

6695

26423

Peripheral artery disease

4718

22087

1.87

273.19

3.5

4.5

245.87

246.50

u/l

0.10

4457

20863

Other diseases of pericardium

685

1709

5.68

271.48

4.9

4.4

261.67

238.22

u/l

2.42

664

1618

Unspecified haematuria

4475

21293

1.88

271.29

4.2

4.5

241.07

246.98

u/l

1.61

4244

20224

Other and unspecified dermatitis

4987

30117

1.78

270.98

5.0

4.4

240.23

243.36

u/l

0.73

4762

28615

Cardiomyopathy

1839

7958

2.67

270.44

7.7

4.8

261.70

242.16

u/l

4.47

1760

7530

Implicit fungal Sepsis, including avohilmo

995

3194

4.09

270.33

6.4

4.1

249.71

244.55

u/l

0.44

951

3019

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5502

34069

1.74

269.68

4.4

244.58

243.27

u/l

0.23

5221

32341

Cytomegaloviral disease, including avohilmo

476

909

9.59

269.40

13.2

5.0

275.53

243.58

u/l

3.56

467

870

Malignant neoplasm of kidney, except renal pelvis

1047

3430

3.80

269.31

4.7

2.3

234.01

234.05

u/l

0.00

1024

3181

Symptoms and signs involving cognition, perception, emotional state and behaviour

8636

38900

1.56

269.24

4.0

4.6

239.55

242.31

u/l

0.83

8149

37052

Gout, strict definition

2309

11184

2.47

269.02

4.4

240.52

245.01

u/l

0.84

2195

10580

Hyperkalaemia

912

2805

4.44

268.39

4.9

4.4

247.33

246.27

u/l

0.07

868

2651

Other functional intestinal disorders

4362

23015

1.86

268.39

4.1

4.4

234.32

248.52

u/l

8.03

4121

21854

Other bacterial intestinal infections, including avohilmo

2486

12190

2.30

267.89

5.8

4.2

242.46

245.07

u/l

0.33

2345

11518

Type 2 diabetes, definitions combined

8129

31333

1.59

267.34

4.0

4.8

237.47

244.75

u/l

4.20

7681

29801

Cytomegaloviral disease

472

902

9.65

267.26

13.3

5.0

275.31

243.73

u/l

3.45

463

863

Disorders of gallbladder, biliary tract and pancreas

8908

37597

1.55

267.13

4.5

4.4

240.80

242.75

u/l

0.44

8490

35691

Diseases of the respiratory system

5252

15511

1.79

266.00

4.6

4.1

240.97

241.46

u/l

0.07

4995

14697

Gastro-oesophageal reflux disease

6157

32925

1.68

265.58

3.9

4.7

233.09

245.05

u/l

10.81

5774

31379

Type 2 diabetes, strict (exclude DM1)

8168

31566

1.58

265.48

4.0

4.8

237.45

244.99

u/l

4.50

7722

30022

Drug-induced neutropenia

988

3241

4.11

262.17

9.0

4.5

255.93

244.94

u/l

1.20

971

3080

Insulin, fast-acting or short human

3653

20532

1.96

259.73

3.8

4.6

238.29

244.31

u/l

2.21

3501

19453

Ascites

1049

3565

3.83

259.37

4.5

264.80

248.92

u/l

1.20

1015

3389

Disorders of lens

6086

23761

1.70

257.97

4.4

4.8

238.43

246.23

u/l

3.04

5771

22695

malignant neoplasm of male genital organs, including Hilmo

2722

8062

2.25

257.04

5.3

2.4

249.67

235.15

u/l

3.42

2619

7505

Chronic myeloproliferative disease

368

610

19.85

255.02

21.3

4.4

463.40

246.70

u/l

35.43

361

574

Abdominal and pelvic pain

8569

28893

1.56

254.80

4.6

4.4

239.02

244.55

u/l

2.05

8160

27468

Enterocolitis due to Clostridium difficile

1373

5429

3.11

252.35

7.0

4.1

249.81

247.16

u/l

0.22

1307

5110

Benign neoplasms

8414

30832

1.55

251.27

4.7

4.3

235.60

243.38

u/l

3.02

8012

29335

Other systemic involvement of connective tissue

2772

14500

2.14

249.28

3.4

4.3

234.50

244.24

u/l

3.69

2619

13711

Other autoimmune haemolytic anaemias

342

538

21.75

248.67

21.8

3.9

304.09

252.19

u/l

4.73

334

511

Disorders of other endocrine glands

4031

23143

1.85

248.08

4.2

4.4

238.07

243.55

u/l

1.29

3806

21962

malignant neoplasm of male genital organs

2657

7941

2.23

246.78

5.3

2.4

250.16

235.24

u/l

3.48

2557

7388

Major coronary heart disease event excluding revascularizations

5635

23362

1.71

246.06

4.4

4.7

253.89

240.15

u/l

5.45

5338

22089

Pregnancy hypertension

2960

13938

2.04

245.56

3.9

4.2

234.13

234.34

u/l

0.02

2834

13298

Non-small cell lung cancer, adenocarcinoma

810

2417

4.36

244.99

4.4

2.3

253.19

234.49

u/l

2.92

795

2240

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

8556

37070

1.53

243.57

4.6

4.4

243.86

242.06

u/l

0.50

8111

35233

Other arthritis (FG)

2914

15557

2.06

242.34

3.8

4.7

237.71

244.64

u/l

1.14

2795

14801

Other acute lower respiratory infections

5063

29984

1.72

242.19

5.2

4.3

240.25

244.08

u/l

1.02

4836

28389

Persons encountering health services for examination and investigation

5298

16107

1.73

241.53

4.7

4.1

235.75

246.94

u/l

5.39

5018

15358

Low back pain

6856

30423

1.60

240.77

4.1

4.5

233.18

243.57

u/l

7.33

6465

29031

Type 2 diabetes, definitions combined, including avohilmo

8020

31305

1.55

240.39

4.0

4.8

237.74

244.80

u/l

3.88

7576

29785

Benign neoplasm: Colon

5434

32480

1.70

240.34

4.2

4.5

237.08

246.60

u/l

2.79

5139

30806

Diabetic nephropathy

2014

9595

2.53

239.94

3.3

4.0

237.23

238.21

u/l

0.16

1948

9045

Myocardial infarction

4681

19853

1.79

238.59

4.4

4.8

252.56

240.04

u/l

4.75

4435

18781

Acute myeloid leukaemia, helper endpoint

305

422

16.54

237.69

24.6

2.1

346.70

234.19

u/l

4.82

299

398

Acute myeloid leukaemia, including Hilmo

305

422

16.54

237.69

24.6

2.1

346.70

234.19

u/l

4.82

299

398

Acute myeloid leukaemia

305

422

16.54

237.69

24.6

2.1

346.70

234.19

u/l

4.82

299

398

Disorders of choroid and retina

7525

35582

1.57

237.50

4.2

4.6

243.11

244.07

u/l

0.16

7120

33781

Use of hypnotics and sedatives

9255

36859

1.50

236.40

4.5

236.49

243.51

u/l

4.52

8770

35091

Genitourinary diseases

4708

13964

1.79

235.73

4.7

239.65

246.52

u/l

1.30

4491

13345

Osteoporosis

2788

13709

2.10

232.70

4.5

4.2

240.75

248.14

u/l

2.57

2613

12917

Fibrosis and cirrhosis of liver

1048

3797

3.59

232.63

3.7

4.6

239.29

244.26

u/l

0.51

1017

3607

Hyperlipidaemia, other/unspecified

3866

20456

1.86

230.97

3.9

4.6

242.36

246.26

u/l

0.97

3662

19385

Atherosclerosis, excluding cerebral and coronary sclerosis

4382

20934

1.81

230.26

3.4

4.4

246.87

246.84

u/l

0.00

4135

19762

Disorders of calcium metabolism

861

2790

4.00

229.46

5.2

4.5

262.32

247.02

u/l

1.71

822

2650

Hypokalaemia

1374

5643

2.88

229.25

3.3

4.5

245.78

243.99

u/l

0.17

1298

5352

Rheumatoid arthritis

3035

14714

2.00

228.73

3.1

4.7

248.47

247.06

u/l

0.20

2881

13970

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

233

253

45.30

228.37

10.5

2.0

202.00

239.23

u/l

7.22

228

237

Acute upper respiratory infections of multiple and unspecified sites

6647

32128

1.59

227.75

5.5

4.2

234.54

243.81

u/l

6.15

6332

30551

Pre-eclampsia

1578

6826

2.57

226.50

4.5

4.3

242.88

235.09

u/l

0.70

1512

6490

Gastroduodenal ulcer

2753

14797

2.07

226.29

3.9

4.5

247.65

250.45

u/l

0.21

2594

14003

Left ventricular outflow tract obstruction (LVOTO), broad definition

1137

4307

3.22

225.87

4.3

5.2

287.80

243.82

u/l

11.21

1100

4133

Other disorders of kidney and ureter

1554

6862

2.73

225.40

4.1

4.6

241.47

244.95

u/l

0.40

1503

6515

Abnormalities of heart beat

3229

17585

1.92

224.51

3.9

4.4

233.98

242.95

u/l

3.11

3048

16664

Cough

3619

19574

1.85

224.12

4.9

4.5

238.42

243.72

u/l

1.36

3450

18607

Fungal Sepsis

656

1846

5.05

222.31

8.5

4.0

260.46

243.23

u/l

1.68

633

1748

Presence of other functional implants

5474

24019

1.67

219.74

4.1

4.3

243.58

243.80

u/l

0.02

5138

22791

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

3211

15580

1.91

219.07

3.8

4.3

233.13

236.02

u/l

0.41

3074

14849

Later onset COPD, excluding more controls

2191

8290

2.28

218.83

3.2

4.0

237.72

246.96

u/l

2.21

2075

7769

Chronic gastritis

2749

14980

2.05

218.69

4.0

4.5

244.99

248.81

u/l

0.48

2574

14181

Other specified/unspecified arthritis

2563

13615

2.07

216.86

3.7

4.8

237.92

246.22

u/l

1.28

2465

12960

Viral infections characterized by skin and mucous membrane lesions

3879

23257

1.80

216.56

6.2

4.4

240.10

243.26

u/l

0.73

3713

22110

Pre-eclampsia or eclampsia

1674

7569

2.45

216.56

4.5

4.4

244.20

235.68

u/l

0.80

1604

7196

Clear cell adenocarcinoma of kidney

616

1673

5.00

215.98

4.9

2.3

222.88

231.52

u/l

1.35

606

1563

Acute bronchitis

3899

22971

1.80

215.82

5.1

4.2

238.18

244.93

u/l

2.00

3717

21652

Cirrhosis of liver, NAS

819

2726

4.20

215.51

3.7

4.5

240.56

246.04

u/l

0.47

798

2599

Aortic valve malfunction, age under 60 years

1066

4009

3.26

215.29

4.3

5.1

288.88

241.58

u/l

12.08

1030

3845

Dizziness and giddiness

6724

35304

1.56

214.84

4.0

4.5

239.92

243.15

u/l

0.95

6346

33587

Glomerulonephritis

1158

4558

3.12

214.72

4.5

4.6

240.18

247.91

u/l

0.98

1124

4327

Hernia

7968

36777

1.51

212.77

4.2

4.6

238.65

243.79

u/l

2.36

7564

34930

Pain in joint

4974

19105

1.69

212.10

3.8

4.6

233.85

245.24

u/l

4.31

4701

18240

Other disorders of urethra and urinary system

6202

28624

1.59

210.83

4.1

4.4

237.96

243.56

u/l

1.96

5857

27213

Other nutritional deficiencies

5655

33979

1.61

208.62

3.7

4.7

235.32

240.54

u/l

1.61

5367

32437

Other retinal disorders

6139

31168

1.59

208.60

3.9

4.5

243.84

244.90

u/l

0.15

5801

29536

Implicit fungal Sepsis

604

1678

5.14

208.60

8.1

4.1

261.52

243.12

u/l

1.71

585

1592

Cerebrovascular diseases

6853

32385

1.56

208.30

4.3

4.6

245.14

245.35

u/l

0.04

6486

30750

Colorectal cancer, including Hilmo

2261

10813

2.14

208.07

3.4

2.2

244.31

236.07

u/l

1.47

2159

9995

Other (not insulin) diabetes medications

8256

33938

1.49

205.79

3.7

4.7

233.84

245.38

u/l

9.76

7779

32296

Diaphragmatic hernia

3504

20856

1.84

205.39

4.0

4.5

237.25

247.02

u/l

4.05

3305

19731

Dorsalgia

8347

30925

1.49

204.63

4.0

4.5

233.38

243.39

u/l

6.20

7879

29501

Malignant neoplasm of mesothelium and soft tissue

546

1418

5.26

203.60

5.0

2.1

265.20

231.73

u/l

1.31

535

1326

Volume depletion

1160

4664

2.98

203.57

3.9

4.3

242.88

248.01

u/l

0.38

1089

4404

Other diseases of urinary system

8497

33603

1.48

203.50

4.2

4.5

235.83

243.28

u/l

3.95

8040

32014

Any operation in hilmo

249

21.74

203.19

4.6

1.7

237.83

206.79

u/l

1.59

236

Pain (limb, back, neck, head abdominally)

6059

19881

1.60

201.75

4.5

4.6

238.28

246.76

u/l

2.65

5746

18938

Spondylopathies

6877

27640

1.55

201.70

3.9

4.6

239.36

245.72

u/l

2.37

6492

26320

Polyneuropathies and other disorders of the peripheral nervous system

2347

12550

2.13

201.61

4.9

4.4

240.13

245.90

u/l

0.98

2239

11874

Pre-eclampsia or poor fetal growth

2102

10556

2.14

201.61

4.1

4.0

238.12

230.95

u/l

0.82

2014

10056

Senile cataract

5562

22077

1.63

201.47

4.3

4.8

240.17

247.16

u/l

2.23

5255

21067

Convulsions, not elsewhere classified

1930

9334

2.22

201.46

3.8

4.0

240.20

239.79

u/l

0.04

1820

8840

Exposure to unspecified factor

8776

42640

1.46

201.26

3.9

4.5

238.92

242.43

u/l

1.33

8329

40563

Malignant immunoproliferative diseases

288

482

23.66

200.80

10.9

4.6

225.26

242.49

u/l

1.44

282

457

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

8691

39715

1.46

199.72

4.5

4.3

235.97

243.59

u/l

4.99

8259

37756

Chronic apical periodontitis

9505

38457

1.44

198.49

4.5

4.3

238.22

241.95

u/l

1.43

9039

36553

ILD, hospital admission 2, with pulmonary infections

1145

4652

2.96

197.30

5.2

3.9

269.50

241.89

u/l

6.41

1099

4365

Gastric ulcer

1906

9537

2.27

196.44

4.0

4.5

249.88

250.55

u/l

0.03

1799

9012

Noninfective enteritis and colitis

4061

25248

1.72

194.72

4.4

4.5

233.35

243.12

u/l

4.58

3863

24001

Disorders of thyroid, IBD co-morbidities

1398

4033

2.57

192.12

5.6

4.9

231.13

249.57

u/l

3.32

1326

3887

Type 1 diabetes

2191

11454

2.09

192.09

3.5

4.8

236.76

243.66

u/l

1.70

2110

10901

Retention of urine

3564

17400

1.81

191.83

3.9

4.5

241.59

247.41

u/l

0.92

3341

16515

Asthma (diagnoses ohter than nonallergic)

7515

42805

1.48

190.83

3.7

4.5

235.52

242.84

u/l

4.64

7158

40656

Other antidepressants

8832

32317

1.45

187.95

3.9

4.7

232.73

245.12

u/l

10.33

8308

30864

Vocal cord dysfunction

1108

3839

2.80

187.65

3.9

5.6

235.47

247.30

u/l

1.46

1051

3688

Dermatitis and eczema

9562

41356

1.42

187.00

4.6

4.4

237.19

243.07

u/l

3.01

9101

39306

Chronic periodontitis, including avohilmo

8521

39102

1.45

186.86

4.6

4.4

239.54

242.81

u/l

1.05

8084

37205

Pneumocystosis

388

876

8.68

186.31

12.2

4.4

270.63

255.11

u/l

0.73

381

838

Pneumocystosis, including avohilmo

388

876

8.68

186.31

12.2

4.4

270.63

255.11

u/l

0.73

381

838

Periodontitis

8527

39114

1.45

186.12

4.6

4.4

239.42

242.79

u/l

1.10

8091

37214

Cardiomyopathies, Primary/intrinsic

1247

5390

2.69

184.98

9.2

4.7

260.56

239.48

u/l

3.90

1195

5095

Other gastritis (incl. Duodenitis)

2195

11747

2.08

184.28

4.2

4.6

234.38

248.14

u/l

5.06

2064

11133

Malignant neoplasm of colon, including Hilmo

1623

7737

2.33

183.94

3.5

2.2

242.20

236.96

u/l

0.70

1545

7147

Type 1 diabetes, wide definition, subgroup 1

1797

8907

2.22

183.80

3.5

4.9

236.31

242.65

u/l

1.37

1732

8479

Fall on same level

9447

36675

1.42

183.56

4.0

4.6

237.28

242.98

u/l

3.13

8952

35011

Benzodiazepine use

8600

41972

1.44

183.32

4.0

4.5

234.30

242.93

u/l

5.96

8053

39998

Early onset COPD, excluding more controls

1728

8457

2.25

183.08

3.9

4.4

240.26

243.95

u/l

0.36

1637

7991

Other necrotizing vasculopathies

908

3460

3.34

182.47

4.3

4.4

246.62

246.75

u/l

0.01

868

3280

3823

23630

1.71

181.49

3.8

4.6

231.50

243.51

u/l

6.31

3645

22438

Other disorders involving the immune mechanism, not elsewhere classified

477

1240

5.58

180.85

6.5

4.9

237.93

254.24

u/l

1.10

462

1183

Lower back pain or/and sciatica

9156

41572

1.42

180.84

4.1

4.5

236.07

242.38

u/l

3.09

8666

39552

Other and unspecified polyneuropathies, also in other diseases

2061

10961

2.15

180.56

4.8

4.5

237.52

245.88

u/l

1.87

1963

10379

Cardiomyopathy (excluding other)

1274

5615

2.62

180.52

9.1

4.7

260.06

238.69

u/l

4.16

1222

5308

Hydronephrosis

1211

5245

2.69

179.19

4.7

4.5

251.80

242.33

u/l

0.97

1172

4938

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1609

7551

2.33

178.62

3.6

4.9

255.89

243.08

u/l

2.33

1561

7190

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

703

2302

3.66

178.22

5.8

2.6

239.98

232.33

u/l

0.94

686

2152

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1525

7010

2.38

178.06

3.6

4.9

256.86

242.95

u/l

2.47

1481

6684

Hypertensive Renal Disease

549

1582

4.71

177.43

3.3

4.4

244.43

247.91

u/l

0.19

534

1476

Pneumonia due to other infectious organisms, not elsewhere classified

484

1283

5.28

177.11

11.3

4.0

269.86

242.09

u/l

2.60

472

1222

Other specific joint derangements/joint disorders

5899

24889

1.54

176.11

3.8

4.7

233.16

242.56

u/l

3.92

5576

23770

Intracranial trauma

4667

20350

1.62

176.11

3.9

4.9

233.80

243.61

u/l

5.05

4408

19506

Gestational [pregnancy-induced] hypertension

1715

8422

2.19

176.07

3.6

4.1

224.07

231.48

u/l

2.08

1642

8021

Biguanides

8029

34832

1.45

174.48

3.6

4.7

232.86

245.65

u/l

11.83

7552

33168

Other noninfective gastroenteritis and colitis

2271

12447

2.00

174.36

5.0

4.6

237.66

244.12

u/l

1.31

2156

11793

Vascular disorders of the intestines

889

3413

3.25

174.25

4.5

4.0

245.28

252.08

u/l

0.54

834

3222

Other diseases of liver

1739

8761

2.23

174.20

3.9

4.7

240.42

240.20

u/l

0.02

1652

8343

1233

5394

2.55

173.39

6.9

4.6

251.45

239.66

u/l

0.69

1175

5118

Suppurative and necrotic conditions of lower respiratory tract

762

2733

3.66

173.06

3.6

4.4

228.39

248.32

u/l

3.15

741

2594

Injuries to the head

9381

41046

1.41

172.50

4.0

4.5

236.93

243.08

u/l

3.63

8860

39088

Other necrotizing vasculopathies (FG)

750

2654

3.59

171.79

3.4

4.6

243.54

243.95

u/l

0.02

715

2508

Other cataract

4025

18991

1.69

171.48

4.4

4.8

235.84

247.74

u/l

6.20

3816

18081

Paralytic ileus and intestinal obstruction

2500

14197

1.93

171.31

4.2

4.4

234.04

251.58

u/l

7.41

2369

13438

Other reaction to severe stress, and adjustment disorders

2766

16023

1.84

171.23

5.3

4.5

237.47

237.63

u/l

0.02

2643

15341

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1487

7145

2.39

171.18

4.7

4.4

243.40

243.10

u/l

0.02

1391

6765

Angina pectoris

4932

21671

1.61

170.65

4.0

4.8

251.66

240.42

u/l

3.42

4686

20498

Malignant neoplasm of head and neck, including Hilmo

938

3678

2.96

169.97

5.2

2.4

237.61

233.18

u/l

0.27

910

3400

Oesophageal varices

597

1888

4.39

169.86

4.3

242.50

247.60

u/l

0.35

579

1792

Colorectal cancer

1971

9950

2.07

169.17

3.4

2.2

243.57

236.04

u/l

1.17

1885

9190

Myocardial infarction, strict

4177

18991

1.67

169.10

4.4

4.8

252.28

240.43

u/l

3.55

3962

17956

Localized swelling, mass and lump of skin and subcutaneous tissue

2901

17251

1.82

168.52

5.7

4.4

235.44

244.43

u/l

2.61

2769

16360

Chronic lower respiratory diseases

9934

38985

1.39

166.76

3.9

4.6

236.84

243.35

u/l

3.81

9455

37068

Diseases of spleen

330

696

8.08

166.41

8.3

4.4

287.21

240.61

u/l

3.04

322

663

ILD, hospital admissions 3, with pneumonia sepsis

1004

4170

2.91

166.28

5.4

3.9

270.57

243.39

u/l

5.16

964

3928

Amputation

1210

5471

2.65

165.76

3.8

4.2

251.08

244.84

u/l

0.67

1147

5157

Weight loss

1161

5155

2.69

165.36

3.5

4.4

228.61

248.79

u/l

4.44

1099

4865

Cutaneous abscess, furuncle and carbuncle

2317

12981

1.94

165.21

5.0

4.7

235.01

240.94

u/l

1.27

2220

12356

Abnormal findings on diagnostic imaging of other body structures

1431

6858

2.38

165.21

4.5

4.4

239.08

245.21

u/l

0.78

1377

6500

Obesity due to excess calories

3859

24665

1.66

164.85

3.6

4.7

233.66

239.51

u/l

1.92

3670

23566

Cellulitis

2096

11433

2.02

164.76

5.0

4.7

243.23

242.88

u/l

0.04

1997

10870

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

7629

43030

1.44

164.65

5.5

4.3

238.66

242.18

u/l

1.42

7297

40913

Myocardial infarction, without ST-elevation

4073

23921

1.67

164.51

3.7

4.4

250.69

247.25

u/l

0.64

3840

22600

malignant neoplasm of female genital organs, including Hilmo

1307

5707

2.41

162.32

4.7

2.2

247.95

236.93

u/l

2.20

1256

5264

Neurological diseases, wide definition

2022

5139

2.08

162.30

4.4

4.8

235.45

251.67

u/l

2.05

1923

4962

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1223

5473

2.52

161.61

5.3

2.0

248.27

239.34

u/l

0.97

1160

5017

Malignant neoplasm of other connective and soft tissue, including Hilmo

496

1408

4.56

161.20

6.4

2.2

284.57

232.03

u/l

2.20

484

1312

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

436

1156

5.41

160.71

6.5

4.8

237.41

254.16

u/l

1.06

423

1103

Abnormal weight loss

1088

4779

2.74

159.63

3.4

4.3

228.61

249.16

u/l

4.14

1027

4513

Intestinal stricture

2991

18262

1.79

159.41

4.3

4.4

235.69

247.13

u/l

4.13

2848

17255

Other dorsopathies, not elsewhere classified

8196

30974

1.42

159.21

3.9

4.5

236.32

243.37

u/l

2.72

7725

29547

Immunodeficiency with predominantly antibody defects

386

942

5.95

158.65

9.9

4.4

237.76

253.77

u/l

0.85

380

901

Obesity

5111

32850

1.54

157.97

3.6

4.6

234.23

240.03

u/l

2.17

4850

31368

Obesity and other hyperalimentation

5131

32988

1.53

157.14

3.6

4.6

234.39

240.07

u/l

2.08

4867

31500

Mycoses

2553

14966

1.86

156.99

5.8

4.5

247.84

242.37

u/l

0.80

2428

14206

Other diseases of intestine

1566

7913

2.23

156.42

4.1

4.6

233.41

249.43

u/l

4.46

1494

7546

Type 1 diabetes, wide definition

1833

9670

2.06

156.34

3.5

4.8

236.08

242.67

u/l

1.58

1766

9200

Seropositive rheumatoid arthritis

2204

12313

1.94

156.19

3.0

4.6

250.06

245.95

u/l

0.66

2100

11642

Malignant neoplasm of head and neck

801

3050

3.09

154.64

5.2

2.4

237.77

232.07

u/l

0.31

778

2830

Other and unspecified aplastic anaemias

241

414

11.75

153.60

12.5

4.1

252.17

247.93

u/l

0.17

234

391

Other CVD

2156

12213

1.98

153.42

3.6

4.1

243.20

250.42

u/l

1.43

2013

11483

Soft tissue disorders

8245

30923

1.41

153.25

4.1

4.6

235.65

244.19

u/l

4.49

7812

29438

Pyothorax

611

2081

3.97

153.22

3.3

4.3

221.90

248.70

u/l

4.76

594

1975

Acute upper respiratory infections

8759

39044

1.39

153.06

5.2

4.1

236.32

243.89

u/l

5.09

8314

37077

Substance abuse, excluding more controls

4744

26763

1.56

152.88

3.1

4.9

231.61

244.06

u/l

5.90

4450

25648

Sulfasalazine

2283

12992

1.89

152.70

3.1

4.4

238.88

239.54

u/l

0.09

2175

12307

Rheumatoid arthritis, including avohilmo

3298

20782

1.71

152.55

3.1

4.5

246.35

243.95

u/l

0.46

3140

19659

Nephrotic syndrome

445

1244

5.06

152.17

4.9

4.8

244.16

258.79

u/l

0.75

434

1186

Zoster [herpes zoster]

1860

10088

2.06

151.15

6.9

4.3

244.85

245.57

u/l

0.07

1771

9520

Malignant neoplasm of prostate, including Hilmo

2357

7805

1.93

151.04

4.9

2.4

249.02

235.53

u/l

2.88

2254

7262

Protozoal diseases

459

1333

5.09

150.94

11.2

4.5

265.80

250.37

u/l

1.05

446

1275

Immunodeficiencies

572

1867

3.93

150.43

8.9

4.4

235.52

251.18

u/l

1.47

561

1777

Peripheral arterial reconstruction

1877

10300

2.08

150.25

3.4

4.2

250.05

247.23

u/l

0.32

1754

9705

Diagnoses used for exclusion with ILD

2418

14171

1.87

150.01

4.1

4.4

242.66

245.76

u/l

0.40

2291

13392

SLE (Finngen)

426

1146

4.86

149.68

3.9

4.5

242.39

254.04

u/l

0.54

415

1088

Other skin changes

1979

10992

2.01

148.90

6.3

4.2

242.35

246.26

u/l

0.48

1887

10398

Fentanyl

1076

4774

2.57

148.55

5.1

4.1

249.01

247.62

u/l

0.08

1018

4490

Malignant neoplasm of prostate

2316

7701

1.93

148.00

4.9

2.3

250.64

235.65

u/l

3.28

2214

7160

Other viral diseases

2282

13047

1.87

147.89

6.9

4.5

246.90

239.15

u/l

1.61

2222

12445

Disorders of parathyroid gland

1966

10780

2.00

147.42

4.0

4.2

237.69

248.18

u/l

2.86

1854

10149

COPD

4299

23417

1.60

147.23

3.5

4.7

239.05

248.41

u/l

4.20

4069

22182

Protozoal diseases, including avohilmo

463

1376

4.86

146.35

11.1

4.5

264.99

250.37

u/l

1.00

450

1314

Malignant neoplasm, without specification of site, including Hilmo

539

1704

3.88

146.20

5.7

2.0

307.73

234.65

u/l

5.12

518

1572

Missing teeth due to accident, extraction or parodontitis

5530

34827

1.50

146.11

4.4

4.5

236.59

244.78

u/l

3.69

5150

33194

Malignant neoplasm of colon

1315

6364

2.30

145.11

3.4

2.1

238.42

237.05

u/l

0.14

1253

5885

Other/unspecified dorsalgia

3176

19743

1.69

144.74

4.2

4.6

235.69

244.56

u/l

2.81

3001

18800

Acute sinusitis

4040

24264

1.59

144.74

5.6

4.3

232.33

241.00

u/l

3.24

3839

23155

Peripheral artery operations in Hilmo

1379

6885

2.29

143.94

3.7

4.3

247.80

246.04

u/l

0.15

1304

6481

Undetermined asthma, excluding more controls

1028

4504

2.51

142.29

4.1

236.87

239.51

u/l

0.17

982

4236

Other coagulation defects

776

3056

3.01

141.32

4.9

4.1

237.29

241.14

u/l

0.27

750

2901

Malignant neoplasm of breast, including Hilmo

2455

9068

1.82

141.18

4.1

2.2

260.87

232.36

u/l

9.01

2319

8426

Malignant neoplasm of breast, HER2-negative, including Hilmo

2454

9068

1.82

140.98

4.1

2.2

260.89

232.36

u/l

9.01

2318

8426

Viral hepatitis, IBD co-morbidity

468

1364

3.92

139.64

3.7

5.5

237.30

246.65

u/l

0.50

444

1311

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

549

1815

3.73

139.15

3.9

2.2

262.50

232.97

u/l

2.04

537

1684

Hypotension

1892

10647

2.00

138.16

3.6

4.1

237.55

249.32

u/l

3.11

1756

9994

Concussion

3945

20190

1.58

137.86

3.7

4.9

234.05

243.81

u/l

4.43

3705

19350

Other respiratory diseases principally affecting the interstitium

1877

10562

2.00

137.25

4.9

4.2

264.34

247.50

u/l

4.37

1798

9961

Candidiasis, including avohilmo

2553

15479

1.77

136.85

4.7

4.3

234.35

240.58

u/l

1.76

2407

14703

Squamous cell neoplasms and carcinomas of the skin

984

4372

2.58

136.11

5.2

2.0

248.87

240.01

u/l

0.78

932

4000

Sequelae of external causes of morbidity and mortality

2372

14213

1.82

135.44

4.8

4.5

239.41

244.11

u/l

0.94

2273

13448

Cardiomyopathy, other and unspecified

776

3117

2.93

135.39

8.2

4.7

264.12

239.31

u/l

2.94

743

2945

Malignant neoplasm of breast, HER2-negative

2396

8963

1.81

135.26

4.1

2.2

262.08

232.72

u/l

9.15

2263

8326

Malignant neoplasm of breast

2398

8975

1.81

135.02

4.1

2.2

262.16

232.68

u/l

9.22

2265

8338

Hypothyroidism, strict autoimmune

5696

26495

1.47

134.96

4.5

4.3

241.97

242.16

u/l

0.03

5401

25098

malignant neoplasm of female genital organs

1133

5186

2.35

134.38

4.6

2.2

248.79

237.42

u/l

2.18

1089

4779

Diseases of the musculoskeletal system and connective tissue

4010

13122

1.59

134.33

4.5

4.6

236.98

248.03

u/l

2.78

3803

12585

Follow-up examination after treatment for conditions other than malignant neoplasms

3266

13752

1.66

134.31

4.2

4.1

235.57

246.65

u/l

3.79

3106

13130

Hepatomegaly and splenomegaly, not elsewhere classified

205

344

11.80

133.21

8.9

4.9

248.80

263.12

u/l

0.36

200

332

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

667

2506

3.16

133.04

3.9

2.2

256.39

234.16

u/l

1.71

649

2326

Diabetic retinopathy, excluding more controls

2435

8059

1.86

132.99

3.6

4.1

235.89

237.63

u/l

0.31

2329

7606

Cardiodefibrillation

3450

22746

1.64

132.91

4.9

4.4

259.86

245.22

u/l

5.12

3289

21573

Other symptoms and signs involving the digestive system and abdomen

1463

7586

2.11

132.67

5.1

4.3

231.33

246.97

u/l

4.93

1371

7180

Other or unspecified ileus, impaction or obstruction

1779

9880

1.98

132.27

4.2

4.4

233.66

252.70

u/l

6.12

1688

9363

Stroke, excluding SAH

5445

28001

1.48

132.06

4.3

4.5

245.65

246.60

u/l

0.18

5149

26532

Stroke, including SAH

5652

29075

1.47

131.87

4.3

4.5

246.46

245.70

u/l

0.13

5343

27566

Other viral diseases, including avohilmo

2824

17462

1.69

131.68

6.4

4.4

244.18

236.80

u/l

1.91

2746

16669

Dysphagia

2308

13805

1.81

131.56

3.9

4.3

235.61

247.53

u/l

3.26

2164

13045

Other diseases of anus and rectum

2697

16707

1.73

131.03

4.6

4.4

236.49

249.52

u/l

4.80

2533

15825

Other chronic obstructive pulmonary disease

4092

22781

1.57

130.94

3.4

4.6

238.19

248.22

u/l

4.78

3869

21575

Hypercalcemia

575

2068

3.67

130.42

5.7

4.2

265.54

248.95

u/l

1.27

547

1948

Spinal stenosis

4567

23285

1.53

129.78

3.8

4.6

245.90

247.63

u/l

0.25

4297

22138

Cholelithiasis, broad definition with cholecystitis

7157

35379

1.40

129.39

4.4

239.35

242.91

u/l

1.08

6799

33548

Other and unspecified coagulation defects

540

1845

3.57

129.08

5.0

4.2

231.54

243.21

u/l

0.92

525

1764

Other and unspecified acquired haemolytic anaemias

213

391

11.85

128.90

16.6

4.0

432.98

241.51

u/l

10.22

201

373

Cystitis

6854

29992

1.41

128.50

4.0

4.4

233.77

243.49

u/l

5.68

6486

28529

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

214

401

12.59

128.32

8.8

4.7

276.71

247.50

u/l

0.76

207

379

Other neurological diseases

6261

35585

1.43

127.84

4.1

4.5

240.10

244.76

u/l

1.78

5914

33749

Alcohol use disorder, Swedish definition

4637

29468

1.50

127.25

3.1

4.8

234.10

243.39

u/l

3.16

4359

28085

Haemorrhage, not elsewhere classified

488

1600

3.88

127.05

6.0

3.6

280.06

243.82

u/l

3.79

461

1512

Chronic periodontitis, complicated

4850

33442

1.49

127.01

4.7

4.6

238.89

243.88

u/l

1.43

4612

31859

Candidiasis

1308

6672

2.19

126.39

5.7

4.3

242.40

241.64

u/l

0.07

1233

6338

Pericarditis

422

1267

4.23

125.71

4.2

4.4

246.58

239.30

u/l

0.34

411

1204

Cystic kidney disease

421

1282

4.43

125.64

3.2

4.5

228.20

250.34

u/l

1.53

415

1215

Hepatic failure, not elsewhere classified

494

1664

3.93

125.28

4.0

4.5

292.88

246.30

u/l

2.40

467

1583

Systemic lupus erythematosus

426

1299

4.24

124.85

3.9

4.5

242.39

246.45

u/l

0.21

415

1242

Nonischemic cardiomyopathy

1032

4882

2.44

124.31

7.8

4.5

258.24

239.89

u/l

2.85

988

4629

Visual disturbances and blindness

4452

31096

1.51

124.21

4.2

4.4

238.37

244.17

u/l

1.50

4189

29521

Osteonecrosis

710

2881

3.01

124.21

7.0

4.5

242.31

245.46

u/l

0.18

686

2741

Obesity related asthma

2892

18517

1.67

124.20

3.6

4.7

237.08

243.55

u/l

1.77

2748

17612

All influenza (not pneumonia)

1233

6177

2.19

123.17

5.7

4.1

242.22

237.53

u/l

0.49

1179

5844

Persons encountering health services for specific procedures, not carried out

794

3345

2.70

123.03

3.8

4.2

230.31

229.46

u/l

0.06

760

3169

SLE, ICD10

409

1230

4.35

122.95

3.9

4.6

242.34

244.66

u/l

0.10

398

1174

SLE, strict definition

409

1230

4.35

122.95

3.9

4.6

242.34

244.66

u/l

0.10

398

1174

Alcoholic liver disease

1058

5097

2.42

122.90

2.5

4.9

248.71

240.72

u/l

0.50

984

4854

Episodal and paroxysmal disorders

8679

33618

1.35

121.92

4.1

4.6

236.84

244.53

u/l

4.04

8198

32026

Non-small cell lung cancer, adenocarcinoma, helper endpoint

810

3553

2.83

121.81

4.4

4.3

253.19

245.95

u/l

0.58

795

3347

Diabetic maculopathy, excluding more controls

1037

4937

2.38

121.45

3.5

4.8

238.39

244.53

u/l

0.84

999

4692

Arthropathies

6884

25670

1.40

121.14

4.1

4.6

233.31

243.29

u/l

5.31

6534

24479

Urinary track infection

3927

13087

1.56

120.84

4.1

233.20

239.94

u/l

1.97

3729

12440

Nerve, nerve root and plexus disorders

8707

40218

1.34

120.78

3.9

4.5

238.50

242.71

u/l

1.50

8232

38248

Amputation of toe

849

3801

2.72

120.70

3.7

4.2

252.98

246.68

u/l

0.59

813

3587

5041

31360

1.46

120.53

3.1

4.8

234.56

242.84

u/l

2.75

4741

29912

Sarcoidosis

1214

6157

2.23

120.36

4.8

4.6

240.52

242.87

u/l

0.19

1159

5863

Cystic kidney disease, including avohilmo

438

1402

4.12

120.20

3.2

4.6

227.61

252.30

u/l

1.95

432

1332

4838

30746

1.47

119.68

3.1

4.8

235.04

242.94

u/l

2.41

4552

29310

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

874

3911

2.57

119.60

5.3

4.2

243.98

244.49

u/l

0.03

837

3718

Osteoporosis with pathological fracture (FG)

776

3322

2.77

119.47

4.2

250.05

253.26

u/l

0.24

726

3120

Colorectal adenocarcinoma

1585

8616

1.97

118.83

3.2

2.2

244.84

236.30

u/l

1.32

1512

7960

Ischaemic Stroke, excluding all haemorrhages

5107

27001

1.47

118.79

4.1

4.5

243.82

246.58

u/l

0.71

4826

25569

Fitting and adjustment of other devices

3111

17939

1.62

118.41

4.2

4.0

239.94

240.25

u/l

0.04

2900

16821

Undetermined asthma

1028

4862

2.31

118.38

4.1

4.2

236.87

242.14

u/l

0.40

982

4576

Malignant neoplasm of other connective and soft tissue

314

808

5.22

118.22

6.4

2.3

299.11

234.69

u/l

1.58

307

760

ILD, hospital admissions

1563

8730

2.03

117.83

4.9

4.3

263.37

246.65

u/l

3.60

1498

8254

Hyperparathyroidism

1691

9501

1.94

117.23

3.8

4.1

235.75

249.00

u/l

3.60

1601

8926

Malignant neoplasm of bladder, including Hilmo

1038

4928

2.33

116.83

4.2

2.1

230.33

236.57

u/l

0.82

985

4547

Mental and behavioural disorders due to psychoactive substance use

4897

32126

1.46

116.71

3.1

4.7

231.84

242.48

u/l

4.78

4596

30638

Diseases of the eye and adnexa

5755

20779

1.43

116.42

4.7

4.6

239.05

241.46

u/l

0.40

5485

19878

Sequelae with surgical and medical care as external cause

1886

11093

1.87

116.32

4.9

4.5

239.75

244.30

u/l

0.78

1811

10498

Congenital malformations, deformations and chromosomal abnormalities

4273

28288

1.49

116.31

4.0

4.6

237.73

239.04

u/l

0.25

4110

26957

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1700

5839

1.92

116.31

3.4

3.7

215.34

222.32

u/l

1.39

1642

5569

Injuries to the abdomen, lower back, lumbar spine and pelvis

3530

23564

1.56

116.22

4.0

4.3

238.10

244.11

u/l

1.82

3302

22295

Diseases of oral cavity, salivary glands and jaws

4857

17586

1.48

116.12

4.3

4.0

242.23

252.53

u/l

3.43

4575

16649

Other chronic obstructive pulmonary disease, including avohilmo

4876

28746

1.47

115.95

3.5

4.6

236.83

247.58

u/l

6.59

4578

27295

Chronic ulcer of skin, not elsewhere classified

780

3412

2.74

115.50

4.3

4.1

249.16

246.15

u/l

0.18

739

3215

Mood disorders, excluding more controls

7455

33151

1.37

115.50

3.9

4.8

231.05

244.29

u/l

11.90

7014

31724

Cholelithiasis

6799

34843

1.38

114.82

4.4

239.77

243.14

u/l

0.95

6454

33028

Other interstitial pulmonary diseases

1577

8900

2.00

114.71

4.8

4.3

263.33

246.90

u/l

3.54

1510

8414

Other obstetric conditions, not elsewhere classified

1729

6013

1.90

114.41

3.4

3.8

215.80

222.56

u/l

1.35

1669

5739

Interstitial lung disease endpoints

1577

8908

2.00

114.38

4.8

4.2

263.33

246.82

u/l

3.58

1510

8423

Interstitial lung disease

1577

8908

2.00

114.38

4.8

4.2

263.33

246.82

u/l

3.58

1510

8423

Substance abuse

4744

31608

1.46

112.50

3.1

4.8

231.61

242.68

u/l

4.96

4450

30148

Noninfectious colitis NAS

1219

6311

2.14

112.47

5.2

4.5

237.37

244.41

u/l

0.81

1160

5987

Eosinophilic disease (BM)

225

466

7.05

112.20

4.3

4.1

251.74

251.72

u/l

0.00

217

440

Zoster [herpes zoster], including avohilmo

4455

30621

1.48

112.00

5.8

4.2

241.94

244.22

u/l

0.51

4249

29005

Symptoms and signs involving the nervous and musculoskeletal systems

4843

34989

1.45

111.67

3.7

4.5

236.76

244.29

u/l

2.57

4595

33245

Malignant neoplasm of eye, brain and central nervous system

421

1344

3.75

111.53

5.5

2.5

243.02

233.73

u/l

0.74

411

1267

Falls/tendency to fall

8288

31882

1.34

111.34

4.1

4.7

236.37

243.78

u/l

4.22

7846

30459

Dental operations

5163

19017

1.46

111.29

4.3

4.1

240.62

250.54

u/l

4.09

4886

18001

Chronic nephritic syndrome

467

1623

3.70

111.19

4.1

4.4

241.33

248.38

u/l

0.45

457

1546

Neurological diseases

6500

24192

1.39

111.17

4.2

4.8

238.23

243.87

u/l

1.39

6165

23177

IgA nephropathy (IgA glomerulonephritis)

327

920

4.96

110.59

4.7

4.8

237.33

240.55

u/l

0.17

320

876

Hepatocellular carcinoma, including Hilmo

361

1073

4.39

110.39

3.6

2.1

244.79

234.51

u/l

0.72

354

992

Visual disturbances

4052

28466

1.50

110.29

4.4

235.76

243.79

u/l

2.98

3825

27024

Acute peritonitis

704

3006

2.82

110.02

4.7

4.2

246.47

246.04

u/l

0.02

690

2861

Diseases of pulp and periapical tissues, including avohilmo

8419

33627

1.34

109.86

4.3

4.4

237.43

244.11

u/l

3.38

8000

31925

Disorders of eyelid, lacrimal system and orbit

7120

39752

1.36

109.73

4.6

4.4

237.83

243.16

u/l

2.07

6769

37757

Myalgia

1913

11372

1.80

109.70

3.7

4.7

230.93

241.90

u/l

3.10

1784

10846

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

982

4792

2.36

109.52

10.8

4.4

249.34

243.61

u/l

0.60

929

4547

Thoracic aortic aneurysm

1466

8216

2.02

109.35

3.7

4.8

252.28

241.95

u/l

1.97

1406

7827

Any mental disorder

8737

33952

1.33

109.26

3.9

4.8

236.40

245.00

u/l

4.71

8208

32481

Budesonide

1142

5816

2.15

108.84

4.4

223.52

236.41

u/l

3.39

1092

5495

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1916

11240

1.78

107.98

3.1

4.7

226.91

237.12

u/l

1.82

1792

10808

Anxiety disorders, excluding more controls

6307

30114

1.38

107.69

4.2

4.8

233.43

243.74

u/l

6.13

5952

28838

Statin medication

4692

18711

1.46

107.49

4.5

4.9

242.80

241.45

u/l

0.17

4454

17823

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

4708

30928

1.44

106.22

4.0

4.6

237.77

239.38

u/l

0.35

4522

29482

External causes of morbidity and mortality

4970

17803

1.45

105.94

4.4

4.6

237.86

245.47

u/l

2.43

4697

17040

Phlebitis and thrombophlebitis (not including DVT)

1927

11643

1.79

105.92

5.5

4.5

244.94

244.23

u/l

0.07

1830

11049

Other external causes of accidental injury

6269

23345

1.39

105.56

4.2

4.8

236.70

246.33

u/l

4.32

5924

22339

Congenital malformations of the urinary system

587

2334

3.00

105.46

3.3

4.8

230.59

251.30

u/l

2.22

580

2232

Other embolism and thrombosis

1193

6290

2.12

105.44

5.6

4.4

248.97

244.62

u/l

0.43

1143

5958

Congenital malformations of the urinary system, including avohilmo

614

2497

2.91

105.02

3.2

4.8

230.07

250.12

u/l

2.30

607

2389

Polymyalgia rheumatica

1354

7498

2.04

104.63

3.1

4.2

239.49

248.45

u/l

1.51

1254

7044

Other joint disorders

6552

25624

1.37

104.40

3.8

4.6

233.49

242.96

u/l

4.58

6185

24434

Other complications of surgical and medical care, not elsewhere classified

885

4195

2.38

104.37

5.2

4.3

241.06

241.38

u/l

0.02

848

3981

Idiopathic gout

1026

5219

2.30

104.14

3.9

4.3

236.53

244.20

u/l

1.09

971

4952

Systemic lupus erythematosus, unspecified

347

1048

4.31

103.57

3.8

4.5

245.90

244.59

u/l

0.05

337

1005

Misadventures to patients during surgical and medical care

1290

7009

2.04

103.44

4.8

4.3

252.37

242.49

u/l

1.07

1237

6658

Coxarthrosis [arthrosis of hip](FG)

4509

22220

1.46

103.26

4.0

4.7

241.95

246.26

u/l

1.07

4247

21092

Colon adenocarcinoma

1005

5010

2.22

102.63

3.1

2.1

239.49

236.99

u/l

0.23

955

4612

Accidents

6242

23345

1.38

102.17

4.2

4.8

237.42

246.33

u/l

3.70

5896

22339

Myocarditis

399

1290

3.55

101.59

6.1

4.9

261.85

233.48

u/l

3.03

387

1225

Dorsopathies

7934

31076

1.33

101.26

4.1

4.5

234.87

243.60

u/l

4.13

7506

29649

Non-allergic asthma (mode), excluding more controls

1291

6923

1.97

100.31

3.9

4.1

240.25

242.10

u/l

0.14

1230

6518

Left ventricular outflow tract obstruction, narrow definition

511

1948

3.17

100.30

3.9

5.1

290.05

254.34

u/l

3.64

496

1862

Other infectious diseases, including avohilmo

904

4418

2.35

100.16

6.0

4.3

244.33

247.05

u/l

0.18

877

4176

Sub-endpoint used in defining T1D endpoints

2317

14547

1.66

99.82

3.5

4.4

235.96

242.54

u/l

1.99

2233

13749

Osteomyelitis

703

3135

2.67

99.47

3.7

4.4

245.35

248.42

u/l

0.20

670

2980

ILD, hospital admissions 1, main diag only

1372

7769

2.00

99.02

5.0

4.3

264.41

245.36

u/l

4.19

1315

7348

Other (seronegative) rheumatoid arthritis, wide

1628

9598

1.85

99.01

3.3

4.4

246.98

244.60

u/l

0.33

1538

9075

Other infectious diseases

783

3645

2.50

98.93

6.4

4.1

248.15

247.33

u/l

0.04

756

3445

COPD, hospital admission 2, with asthma infections

3026

17705

1.58

98.67

3.5

4.4

237.73

248.78

u/l

4.44

2846

16726

Seropositive rheumatoid arthritis, wide

2202

14014

1.69

98.35

3.0

4.4

250.08

244.38

u/l

1.17

2099

13237

Benign neoplasm of other and ill-defined parts of digestive system

1601

9441

1.87

98.15

4.5

233.51

244.35

u/l

2.70

1517

8931

Diseases of pulp and periapical tissues and dental caries

5484

20767

1.41

98.07

4.3

4.2

240.37

250.22

u/l

4.42

5191

19654

Need for other prophylactic measures

598

2490

2.86

98.07

5.3

4.6

244.68

249.99

u/l

0.29

588

2375

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

501

1906

3.10

97.45

3.9

2.2

260.86

233.12

u/l

1.70

486

1763

Other and unspecified drugs and medicaments

812

3845

2.42

97.28

5.1

4.4

244.26

247.08

u/l

0.18

777

3645

3834

24609

1.49

96.85

5.0

4.1

248.04

247.16

u/l

0.11

3625

23226

COPD, early/later onset

4137

25049

1.47

96.65

3.4

4.5

238.78

247.42

u/l

3.48

3907

23731

Persons with potential health hazards related to communicable diseases

2515

16262

1.60

96.53

4.3

4.5

231.84

235.16

u/l

0.60

2428

15553

In situ neoplasms

3405

23803

1.51

96.22

5.0

4.1

244.21

244.31

u/l

0.01

3259

22467

Disorders of the thyroid gland

7503

37888

1.32

96.20

4.7

4.3

239.75

241.84

u/l

0.56

7116

35991

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2140

13607

1.69

96.04

3.0

4.5

250.37

244.46

u/l

1.19

2041

12855

Aortic aneurysm

2230

14081

1.68

95.81

3.7

4.5

254.16

245.87

u/l

1.58

2125

13338

Collagenous colitis

866

4227

2.33

95.73

4.9

4.4

231.49

246.83

u/l

2.61

820

4015

Gonarthrosis [arthrosis of knee](FG)

5755

24810

1.38

95.31

4.0

4.7

240.88

245.03

u/l

1.17

5409

23567

Other intervertebral disc disorders

6418

29144

1.36

95.26

4.0

4.6

237.38

244.49

u/l

2.70

6053

27787

Acute posthaemorrhagic anaemia

402

1390

3.59

95.15

4.4

4.0

256.16

250.71

u/l

0.20

371

1317

Asthma, hospital admissions , main diagnosis only

6389

42652

1.35

95.15

3.7

4.5

236.64

242.89

u/l

2.78

6071

40550

Urticaria and erythema

2689

17915

1.58

94.97

5.1

4.4

241.37

240.78

u/l

0.06

2553

17054

COPD, hospital admissions

4088

24874

1.47

94.87

3.4

4.5

238.50

247.49

u/l

3.71

3860

23569

Injuries to the thorax

3960

28463

1.46

94.59

4.2

4.5

235.11

245.07

u/l

6.02

3713

27031

Secondary polycythaemia

309

927

4.46

94.16

3.2

4.3

234.74

250.42

u/l

0.74

287

878

Other/unspecified seropositive rheumatoid arthritis

2165

13870

1.68

93.98

3.0

4.4

250.30

244.54

u/l

1.17

2063

13099

Open wound of head

4631

32040

1.42

93.77

3.9

4.6

240.05

246.16

u/l

1.91

4357

30467

Malignant neoplasm of small intestine, including Hilmo

334

1045

4.04

93.57

6.2

2.2

233.71

233.11

u/l

0.04

318

977

Skin changes due to chronic exposure to nonionizing radiation

3660

23638

1.49

92.98

5.1

4.1

248.79

247.17

u/l

0.21

3465

22306

Diseases of the myoneural junction and muscle

1157

6326

2.05

92.18

3.2

4.5

260.15

245.80

u/l

2.28

1077

5983

Other respiratory disorders and diseases

1891

11825

1.74

92.04

4.0

4.3

260.26

247.72

u/l

2.36

1791

11129

Other diseases of the respiratory system

1891

11825

1.74

92.04

4.0

4.3

260.26

247.72

u/l

2.36

1791

11129

Polyarthrosis

1743

9535

1.77

91.97

3.7

4.8

236.08

249.15

u/l

4.37

1610

9036

Malignant neoplasm of ovary, including Hilmo

481

1829

3.00

91.97

5.0

2.3

258.87

232.20

u/l

3.26

464

1694

Malignant neoplasm, without specification of site

353

1146

3.76

91.94

5.6

2.0

323.52

235.39

u/l

3.72

337

1056

Actinic keratosis

3575

23160

1.50

91.91

5.1

4.1

249.23

247.46

u/l

0.23

3381

21850

Sleep apnoea

7485

36941

1.32

91.75

3.9

4.7

236.31

244.41

u/l

5.16

7062

35227

Congenital malformations of aortic and mitral valves

446

1667

3.27

91.36

3.9

4.9

287.70

251.35

u/l

4.09

433

1595

Charcot foot

243

633

5.34

91.15

3.6

5.2

231.45

239.52

u/l

0.60

233

601

Methotrexate

1093

5834

2.04

91.04

2.9

4.3

242.47

241.33

u/l

0.12

1034

5502

Congenital malformations of heart and great arteries

1038

5290

2.10

91.03

3.9

4.9

273.98

244.68

u/l

5.43

1005

5039

Malignant neoplasm of liver and intrahepatic bile ducts

351

1151

3.80

90.85

4.0

2.1

250.56

234.05

u/l

1.65

343

1067

Obesity, other/unspecified

2417

15888

1.60

90.71

3.7

4.6

230.32

237.97

u/l

1.94

2297

15174

Problems related to lifestyle

851

4166

2.25

90.67

3.1

4.8

229.53

237.29

u/l

0.88

805

3956

Inflammatory bowel disease

2378

15609

1.61

90.60

3.9

4.8

226.34

239.89

u/l

6.73

2274

14846

Coronary artery bypass grafting

2378

11554

1.65

90.42

3.5

4.6

257.24

241.45

u/l

4.92

2261

10869

Malignant neoplasm of small intestine

270

757

4.69

90.14

6.0

2.3

230.69

235.56

u/l

0.35

255

708

Viral pneumonia (known virus, not influenza)

368

1266

3.82

90.06

8.7

4.5

251.66

254.07

u/l

0.09

350

1203

Other specified/unspecified systemic involvement of connective tissue

537

2204

2.86

89.83

3.5

4.6

242.79

246.84

u/l

0.24

519

2091

Neurotic, stress-related and somatoform disorders

6571

34983

1.33

89.37

4.2

4.6

231.71

242.00

u/l

7.01

6207

33394

Other disorders of lacrimal gland

2929

20156

1.53

89.25

4.8

4.4

237.62

244.45

u/l

1.38

2766

19091

COPD related to multimorbidity

3646

22086

1.48

89.08

3.3

4.5

240.48

248.13

u/l

2.45

3437

20902

Depression or dysthymia

5330

21755

1.39

89.06

4.0

5.1

232.94

248.73

u/l

10.18

5020

20889

Fracture of lumbar spine and pelvis

2038

13028

1.68

88.86

4.3

4.1

242.08

246.45

u/l

0.78

1909

12258

Disorders of lacrimal system

3508

24539

1.47

88.72

4.7

4.4

237.38

243.95

u/l

1.61

3322

23240

Malignant neoplasm of breast, ER-positive, including Hilmo

1802

8143

1.72

88.49

3.7

2.1

262.95

234.09

u/l

5.72

1703

7562

COPD, hospital admissions 3, with asthma pneumonia sepsis

2584

14913

1.60

88.43

3.6

4.3

239.06

248.39

u/l

2.80

2428

14061

Diseases of peritoneum

938

4853

2.18

88.32

4.5

4.4

244.76

246.08

u/l

0.09

911

4601

Anxiety disorders

6646

35357

1.33

88.03

4.2

4.6

232.16

241.82

u/l

6.00

6281

33738

Covid-19 suspected case

1535

9115

1.79

88.01

5.0

4.4

237.68

237.03

u/l

0.06

1494

8646

Coxarthrosis

4091

19078

1.44

87.91

4.0

4.8

242.15

247.48

u/l

1.30

3856

18122

Malignant neoplasm of breast, HER-positive

1794

8133

1.72

87.44

3.7

2.1

262.92

234.13

u/l

5.66

1696

7552

Benign neoplasm: Colon, unspecified

2292

15172

1.63

87.36

3.9

4.5

242.06

246.06

u/l

0.29

2132

14373

Acute pancreatitis

1684

10343

1.76

87.24

4.3

4.6

245.24

245.39

u/l

0.01

1587

9790

Nonalcoholic fatty liver disease

861

4325

2.22

87.02

3.5

4.8

229.67

241.17

u/l

2.11

819

4124

Caries of dentine, including avohilmo

6386

25081

1.34

86.94

4.3

4.4

239.21

248.26

u/l

4.68

6047

23802

Depression

7241

38011

1.31

86.81

3.9

4.6

230.09

242.87

u/l

11.42

6831

36263

Irritable bowel syndrome

1996

12707

1.66

86.51

3.6

4.5

227.31

245.02

u/l

6.57

1863

12107

Dental caries, including avohilmo

5992

23396

1.36

86.25

4.3

240.68

248.98

u/l

3.68

5680

22162

Sciatica+with lumbago

4009

25830

1.43

86.19

3.9

4.7

237.85

243.88

u/l

1.26

3820

24647

Malignant neoplasm of stomach, including Hilmo

531

2196

2.77

86.13

4.1

2.1

256.28

234.64

u/l

0.45

505

2036

Asthma, including avohilmo

9308

41334

1.27

85.88

3.7

4.6

234.53

243.65

u/l

7.42

8844

39288

L02BX Other hormone antagonists and related agents

710

3442

2.58

85.87

6.8

4.4

269.56

241.66

u/l

3.23

688

3264

Spondylosis

4392

25325

1.41

85.74

3.8

4.6

236.64

245.99

u/l

4.83

4147

24139

Adrenocortical insufficiency

391

1411

3.41

85.66

5.0

4.7

256.02

251.70

u/l

0.09

376

1341

Fracture of rib(s), sternum and thoracic spine

2704

18535

1.55

85.37

4.3

4.4

235.32

246.35

u/l

5.11

2524

17562

Mood disorders

7867

39948

1.29

85.25

3.9

4.6

230.07

243.20

u/l

13.18

7414

38082

Substance use, excluding alcohol

1466

8690

1.80

85.09

3.1

5.0

226.35

238.41

u/l

2.98

1356

8326

Mood [affective] disorders

7844

39903

1.29

84.98

3.9

4.6

230.13

243.11

u/l

12.86

7395

38037

Gingivitis and periodontal diseases

7883

32226

1.30

84.92

4.6

4.3

239.98

245.34

u/l

2.26

7452

30628

Unspecified acute lower respiratory infection

1306

7540

1.88

84.81

6.0

4.5

250.37

242.14

u/l

0.86

1263

7144

Primary Sclerosing Cholangitis, IBD and UDCA required

256

719

4.60

84.73

3.9

4.8

227.99

247.06

u/l

1.27

250

689

Seronegative rheumatoid arthritis

967

5095

2.09

84.72

3.5

4.7

245.89

244.86

u/l

0.09

916

4843

Other diseases of arteries and capillaries

844

4272

2.23

84.42

4.0

4.3

246.55

243.29

u/l

0.17

809

4042

Sicca syndrome [Sjögren]

729

3495

2.36

84.10

3.4

4.5

233.72

246.51

u/l

1.80

701

3310

Non-small cell lung cancer, squamous

460

1800

2.95

83.89

4.4

2.0

222.86

237.36

u/l

2.49

449

1651

Other inflammatory liver diseases

624

2828

2.56

83.70

4.3

4.6

250.99

243.97

u/l

0.45

596

2687

Other metabolic disorders

987

5229

2.05

83.60

8.1

4.4

235.98

239.77

u/l

0.37

947

4983

Congenital malformations of the circulatory system

1132

6103

1.97

83.38

4.1

4.9

271.62

243.52

u/l

5.72

1086

5824

Functional dyspepsia

2045

13257

1.63

82.65

4.1

4.6

229.41

245.12

u/l

7.30

1929

12590

Other disorders of adrenal gland

454

1797

3.01

82.43

4.8

4.5

254.33

251.25

u/l

0.08

437

1712

Chronic pancreatitis

1134

6379

1.98

82.33

3.4

4.8

232.91

243.09

u/l

1.29

1085

6053

Respiratory insufficiency

708

3363

2.34

81.87

3.4

4.0

261.15

248.23

u/l

0.98

664

3149

Drug-induced osteoporosis with pathological fracture

243

696

5.12

81.61

4.8

4.3

251.00

250.75

u/l

0.01

228

655

Crohn disease

1010

5460

2.02

81.03

3.7

4.8

224.82

238.52

u/l

2.90

968

5202

Other diseases of hard tissues of teeth

4543

17394

1.40

81.02

4.3

4.1

238.33

252.62

u/l

6.60

4297

16486

DVT of lower extremities

1620

10050

1.74

80.83

4.9

4.4

245.11

246.25

u/l

0.11

1528

9511

Arthropathies in other diseases classified elsewhere

390

1451

3.29

80.71

3.3

4.9

228.77

246.89

u/l

2.18

373

1386

Osteonecrosis due to drugs

234

664

5.41

80.67

11.0

4.5

251.55

245.69

u/l

0.16

224

632

Amyloidosis

301

985

4.08

80.45

6.2

4.6

239.94

240.63

u/l

0.04

295

936

Vitreous haemorrhage

953

5128

2.09

80.16

4.3

4.5

246.77

244.79

u/l

0.14

910

4867

Exclusions for E4_PCOS_BROAD

1334

7857

1.83

79.86

4.4

4.7

244.39

241.81

u/l

0.17

1269

7491

Unspecified fall

4175

30486

1.40

79.85

3.7

4.5

237.51

245.38

u/l

3.54

3927

28937

Sleep disorders (combined)

8707

36682

1.27

79.75

3.8

4.6

233.06

245.29

u/l

12.36

8225

34962

Malignant neoplasm of bone and articular cartilage

147

285

7.87

79.56

8.4

2.1

234.06

232.69

u/l

0.05

147

267

Colectomy operation

1505

9239

1.78

79.50

4.1

4.4

229.36

245.01

u/l

5.07

1440

8735

Eosinophilia

226

622

5.17

79.42

4.9

4.4

252.31

242.28

u/l

0.27

218

594

Hypothyroidism, other/unspecified

6818

35338

1.31

79.25

4.6

4.3

240.58

241.50

u/l

0.19

6464

33562

Elevated blood glucose level

768

3844

2.25

79.15

4.0

4.3

241.10

245.01

u/l

0.29

728

3647

Abnormal results of function studies

767

3826

2.24

79.09

4.3

4.4

237.08

244.13

u/l

0.68

714

3636

Autoimmune hepatitis, wide definition

433

1703

2.97

78.81

4.3

4.4

251.61

245.30

u/l

0.27

414

1619

Malignant neoplasm of breast, ER-negative, including Hilmo

1256

6778

1.84

78.38

4.5

2.2

252.12

235.42

u/l

3.33

1179

6269

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3526

25424

1.44

78.20

3.0

4.8

232.81

242.63

u/l

3.00

3318

24223

Psychiatric diseases

7619

30353

1.29

78.17

4.0

4.9

236.65

246.35

u/l

4.97

7168

29049

Disturbances of skin sensation

1969

12800

1.62

78.12

3.9

4.3

226.60

238.75

u/l

4.06

1857

12184

Gonarthrosis

4893

20823

1.37

78.08

4.0

4.8

240.24

246.19

u/l

1.82

4608

19793

Diabetic retinopathy

3110

13705

1.51

77.87

3.5

3.9

238.82

237.98

u/l

0.14

2957

12968

Allergic asthma (mode), excluding more controls

1307

7429

1.79

77.86

3.5

3.9

227.76

234.59

u/l

1.18

1251

7057

Isolated proteinuria

327

1137

3.66

77.63

5.3

4.3

226.63

249.13

u/l

1.93

318

1081

Hepatocellular carcinoma

268

825

4.18

77.59

3.5

2.1

241.02

236.48

u/l

0.24

262

761

Cholangitis (primary sclerosing, PSC)

631

2969

2.46

77.56

3.7

4.3

247.38

248.94

u/l

0.07

605

2810

Mental and behavioural disorders due to alcohol

4022

28450

1.40

77.30

3.1

4.8

233.53

243.14

u/l

3.16

3787

27134

Injury, poisoning and certain other consequences of external causes

3931

14281

1.42

77.30

4.4

4.5

238.97

246.36

u/l

1.66

3737

13655

Bicuspidal aortic valve syndrome

390

1487

3.19

77.05

3.6

4.9

283.65

245.55

u/l

5.48

377

1423

Insulin, fast-acting (human)

1054

5860

1.94

76.76

3.4

4.5

239.34

239.57

u/l

0.02

1015

5559

Postprocedural endocrine and metabolic disorders, not elsewhere classified

900

4758

2.05

76.73

8.5

4.4

234.17

239.44

u/l

0.56

861

4533

Non-allergic asthma (mode)

1291

7508

1.80

76.58

3.9

4.2

240.25

244.58

u/l

0.40

1230

7077

Arthrosis

5279

22083

1.35

75.80

4.0

4.7

237.01

245.52

u/l

3.72

4976

21002

Mycoses, including avohilmo

7136

43405

1.29

75.69

4.5

4.4

238.80

241.60

u/l

0.70

6741

41349

Personality disorders, excluding more controls

1633

10181

1.68

75.62

3.2

4.9

224.01

236.61

u/l

3.70

1538

9790

Cardiac arrest

541

1990

2.56

75.51

5.0

275.29

235.54

u/l

6.88

511

1880

Open wound of lower leg

1285

7632

1.82

75.49

3.5

4.7

240.61

243.46

u/l

0.35

1219

7242

Intracranial injury

4694

33322

1.36

75.17

3.8

4.5

235.91

244.55

u/l

4.64

4406

31693

Acute pancreatitis (for exclusion)

1684

10734

1.69

75.09

4.3

4.5

245.24

243.35

u/l

0.13

1587

10181

Hypothyreosis and Thyroxine purchase for inclusion criteria

7053

36814

1.29

74.91

4.6

4.3

240.43

241.42

u/l

0.21

6688

34956

Viral and other specified intestinal infections, including avohilmo

1893

11794

1.61

74.85

4.6

4.2

234.61

236.98

u/l

0.26

1807

11227

Disorder of lipoprotein metabolism, unspecified

1163

6774

1.89

74.41

3.6

4.6

248.75

247.15

u/l

0.12

1104

6410

Decubitus ulcer and pressure area

654

3181

2.39

74.28

4.1

4.0

241.08

247.43

u/l

0.48

613

2988

Alcohol use disorder, ICD-based

3258

23609

1.44

74.27

2.9

4.9

231.88

242.19

u/l

3.01

3065

22505

Malignant neoplasm of bladder

595

2754

2.42

74.14

4.1

2.0

230.34

237.50

u/l

0.61

570

2530

Anxiety (asthma-related co-morbidities)

4069

22990

1.39

73.57

3.7

4.8

224.94

240.66

u/l

11.54

3837

22045

Unstable angina pectoris

3065

17249

1.47

73.28

3.7

4.6

251.95

241.89

u/l

1.62

2897

16256

Subjective visual disturbances

2000

13291

1.60

72.85

4.0

4.5

235.58

243.01

u/l

1.23

1891

12606

Biological medication for rheuma

1244

7360

1.80

72.70

2.8

4.9

224.58

238.05

u/l

4.23

1193

7030

Drug-induced cataract

282

939

3.91

72.69

7.1

4.7

238.60

249.85

u/l

0.55

272

894

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1916

12564

1.60

72.44

3.1

4.6

226.91

234.59

u/l

1.18

1792

12018

COPD-related respiratory insufficiency

1131

6617

1.90

72.44

3.3

4.3

242.47

247.17

u/l

0.65

1071

6248

Poisoning by drugs, medicaments and biological substances

1600

10085

1.67

72.37

2.9

4.7

233.72

236.62

u/l

0.25

1501

9636

Malignant neoplasm of oropharynx, including Hilmo

227

657

4.45

72.05

6.0

2.1

232.01

232.14

u/l

0.01

221

618

Vitamin B12 deficiency anaemia

907

4953

2.02

71.76

4.0

4.1

265.26

251.52

u/l

0.72

860

4676

Abnormalities of gait and mobility

1143

6724

1.89

71.69

3.0

4.4

235.22

246.46

u/l

1.77

1074

6356

Other and unspecified local infections of skin and subcutaneous tissue

856

4599

2.06

71.38

4.6

241.97

242.73

u/l

0.04

834

4362

Hypocalcemia

285

967

3.84

71.28

4.2

4.5

264.50

252.72

u/l

0.43

275

919

Asthma/COPD (KELA code 203)

7252

38949

1.28

71.21

3.5

4.6

236.27

243.12

u/l

3.40

6885

37033

Other disorders of ear

7152

37109

1.28

71.08

4.3

4.5

238.50

243.79

u/l

2.59

6738

35336

Gout due to impairment of renal function

190

515

6.04

70.92

3.7

4.7

243.36

247.30

u/l

0.17

182

491

Chronic tubulo-interstitial nephritis

355

1334

3.14

70.90

3.6

4.2

228.52

251.27

u/l

1.70

344

1256

Injuries to the hip and thigh

4093

27700

1.38

70.61

3.8

4.3

242.15

246.11

u/l

0.90

3826

26213

Other disorders of glucose regulation and pancreatic internal secretion

735

3767

2.18

70.51

3.3

4.4

240.12

248.62

u/l

0.71

699

3580

Other local infections of skin and subcutaneous tissue

897

4910

2.02

70.45

4.6

4.7

241.10

242.41

u/l

0.08

872

4657

Artificial opening status

538

2474

2.54

70.32

3.8

4.2

241.27

245.92

u/l

0.23

520

2340

Amiodarone users

976

5547

2.00

70.19

7.8

4.5

263.55

244.66

u/l

2.90

945

5249

Abnormal findings on examination of urine, without diagnosis

451

1929

2.79

70.17

5.1

4.3

227.00

247.80

u/l

3.10

436

1835

Cholangitis (primary sclerosing, PSC), with reimbursement 202

218

628

4.51

69.88

3.5

5.3

223.66

237.78

u/l

1.10

211

606

Other symptoms and signs involving cognitive functions and awareness

3975

26538

1.39

69.82

3.5

4.5

241.40

246.21

u/l

1.00

3697

25188

Dilated cardiomyopathy

1099

6456

1.90

69.70

9.9

4.5

261.35

242.85

u/l

2.98

1053

6122

Primary biliary cholangitis, wide definition

252

796

3.99

69.64

3.8

4.4

237.34

249.37

u/l

0.39

243

753

Malignant neoplasm of stomach

451

1909

2.69

69.57

3.9

2.0

260.57

232.85

u/l

0.50

428

1773

Poisoning by medicine

1447

8997

1.70

69.34

2.8

4.7

233.98

236.83

u/l

0.22

1359

8608

Personal history of malignant neoplasm

653

3211

2.25

69.30

5.3

4.3

259.98

244.18

u/l

0.94

636

3049

Exclusions for E4_PCOS_CONSORTIUM

4766

22729

1.35

69.28

4.1

4.2

237.01

239.69

u/l

0.61

4502

21614

Shoulder lesions

5787

27199

1.31

69.27

4.0

4.6

235.61

245.52

u/l

5.30

5485

25873

Other anxiety disorders

3054

18681

1.44

69.16

3.5

4.5

224.34

237.88

u/l

6.61

2888

17886

Herpesviral [herpes simplex] infections

931

5185

1.96

68.41

6.4

4.4

242.59

242.82

u/l

0.02

891

4921

Other viral diseases, not elsewhere classified, including avohilmo

1811

11810

1.60

68.34

5.4

4.5

240.76

239.25

u/l

0.18

1758

11249

Hernia of abdominal wall

3667

27468

1.39

68.10

4.1

4.6

239.36

244.41

u/l

1.10

3498

26096

Other and unspecified myopathies

834

4540

2.07

67.97

3.0

4.2

264.81

245.96

u/l

2.71

772

4283

Viral and other specified intestinal infections

1403

8470

1.70

67.63

5.0

4.1

234.89

237.58

u/l

0.24

1338

8061

Transient ischemic attack

4383

26749

1.36

67.55

4.2

4.4

241.65

246.44

u/l

1.58

4146

25321

Ventral hernia

1948

13113

1.58

67.24

4.2

4.5

239.36

246.00

u/l

0.95

1849

12397

5-aminosalicylic acid

1408

8759

1.69

67.11

3.9

4.5

224.90

235.26

u/l

3.13

1343

8314

Other viral diseases, not elsewhere classified

1321

8090

1.73

66.95

5.9

4.7

243.33

241.83

u/l

0.14

1283

7695

Sleep apnoea, including avohilmo

7646

37598

1.26

66.88

3.8

4.7

236.04

244.15

u/l

5.27

7210

35870

Malignant neoplasm of breast, HER-negative

1142

6453

1.80

66.81

4.5

2.2

254.79

235.71

u/l

3.66

1070

5959

Intestinal adhesions without obstruction

762

4032

2.11

66.79

4.4

230.02

251.09

u/l

3.77

722

3836

Degeneration of macula and posterior pole

4225

24912

1.37

66.64

3.9

4.4

247.94

246.95

u/l

0.10

3960

23551

Folate deficiency anaemia

165

416

6.01

66.23

5.1

4.6

287.91

247.47

u/l

0.99

159

397

Other disorders of veins

3059

21981

1.43

66.07

3.8

4.4

242.44

242.88

u/l

0.06

2884

20837

All anxiety disorders

4132

24309

1.36

65.57

3.7

4.6

224.51

239.81

u/l

11.23

3893

23270

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

309

1121

3.19

65.17

3.5

5.0

241.02

237.41

u/l

0.19

302

1075

Procreative management

2110

11803

1.53

65.17

5.7

4.6

238.01

241.13

u/l

0.41

2015

11274

Complications of internal orthopaedic prosthetic devices, implants and grafts

1897

12808

1.58

65.09

3.6

4.2

242.07

246.91

u/l

0.87

1768

12079

Chronic hepatitis, not elsewhere classified

338

1308

3.10

64.52

3.7

4.7

257.45

249.27

u/l

0.21

331

1253

Other arthrosis

3982

20164

1.37

64.38

3.8

4.8

240.03

246.07

u/l

1.62

3772

19199

Spondylopathies in diseases classified elsewhere

192

554

5.11

64.07

10.2

4.6

244.90

247.62

u/l

0.11

187

525

Allergic asthma (mode)

1307

7833

1.69

63.96

3.5

4.0

227.76

236.20

u/l

1.69

1251

7440

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2458

17409

1.48

63.91

4.9

4.5

234.51

242.76

u/l

2.26

2331

16541

Pruritus

918

5193

1.92

63.90

4.5

4.2

240.95

244.73

u/l

0.39

868

4927

Disorders of sclera, cornea, iris and ciliary body

4134

31713

1.35

63.89

4.4

4.5

238.88

242.52

u/l

0.74

3952

30129

Other pulmonary heart/vessel disease

481

2214

2.58

63.50

5.7

4.0

286.17

245.98

u/l

3.47

466

2087

Other diseases of stomach and duodenum

595

2955

2.28

63.05

3.8

4.5

227.21

253.52

u/l

5.24

566

2806

Disorders of skin appendages

3526

26320

1.38

63.04

4.9

4.5

233.90

239.29

u/l

1.54

3352

25097

Secondary right heart disease

442

1974

2.68

62.89

5.9

3.9

289.69

245.55

u/l

3.60

429

1858

Other/unspecified rheumatoid arthritis

1028

6067

1.86

62.82

3.1

4.2

250.17

247.02

u/l

0.33

968

5719

Polyuria

1901

12939

1.57

62.69

3.9

4.6

230.35

247.87

u/l

6.72

1774

12294

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

446

1944

2.49

62.54

3.6

4.5

214.54

234.78

u/l

3.13

426

1859

Unspecified privation

884

5010

1.94

61.92

4.1

4.4

235.13

245.08

u/l

1.52

845

4759

Malignant neoplasm of ovary

348

1374

2.87

61.84

5.4

2.4

253.94

230.09

u/l

2.59

335

1274

Other or ill-defined heart diseases

434

1896

2.55

61.74

5.8

4.4

249.67

236.37

u/l

0.88

410

1795

Epilepsy

2363

16684

1.48

61.24

4.3

4.6

243.98

247.36

u/l

0.31

2237

15857

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

166

10.08

60.80

8.2

2.3

224.24

233.62

u/l

0.46

159

Soft tissue disorders related to use, overuse and pressure

2138

14914

1.51

60.73

4.0

4.8

242.88

246.82

u/l

0.34

2025

14203

Spondyloarthritis

1318

8300

1.69

60.56

3.5

4.6

229.61

240.84

u/l

2.75

1249

7856

Ulcerative colitis

1748

11718

1.57

60.47

3.9

4.7

226.94

239.09

u/l

4.31

1666

11154

Other diseases of biliary tract

792

4391

2.01

60.45

4.6

4.2

262.39

250.18

u/l

0.51

761

4138

Hypothyroidism, strict autoimmune, 3 medication purchases required

6228

33712

1.27

60.41

4.4

4.2

242.29

241.37

u/l

0.17

5904

31994

Hypoglycaemia, other or unspecified

585

2925

2.24

60.30

3.5

4.3

238.99

247.42

u/l

0.61

557

2792

Stomatitis and related lesions

1494

9722

1.63

59.97

5.5

4.6

243.57

241.80

u/l

0.15

1429

9236

Benign neoplasm: Ascending colon

1252

7902

1.73

59.70

4.2

4.5

226.21

244.12

u/l

7.53

1195

7491

Seropositive rheumatoid arthritis, strict definition

1158

7130

1.75

59.60

3.0

4.6

250.69

244.11

u/l

0.82

1108

6764

Fibromyalgia

639

3278

2.11

59.46

2.6

4.5

210.69

244.62

u/l

13.66

596

3129

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

179

502

4.57

59.42

3.8

2.2

273.74

227.91

u/l

1.79

174

473

Malignant neoplasm of endocrine gland, including Hilmo

523

2497

2.28

59.19

5.5

2.4

236.38

229.03

u/l

0.77

501

2333

Personal history of other diseases and conditions

697

3663

2.02

58.87

5.8

3.9

261.00

234.17

u/l

1.25

659

3477

Other and unspecified effects of external causes

1871

12771

1.53

58.73

3.9

4.6

228.66

239.00

u/l

2.98

1775

12165

Other viral hepatitis

464

2132

2.42

58.65

3.6

4.9

238.76

239.52

u/l

0.03

443

2039

Other headache syndromes

2901

21302

1.41

58.50

3.7

4.6

228.19

243.28

u/l

8.62

2731

20325

L02BB Anti-androgens

957

5706

1.89

58.50

6.3

4.1

268.38

245.16

u/l

2.64

919

5366

Benign neoplasm: Stomach

847

4848

1.94

58.48

4.8

4.4

235.60

247.66

u/l

1.50

801

4581

Other general symptoms and signs

382

1593

2.63

58.48

3.1

3.7

253.43

240.78

u/l

0.35

369

1512

Abnormal serum enzyme levels

2631

18587

1.45

57.83

4.7

4.6

252.90

244.40

u/l

1.29

2546

17658

Other viral hepatitis, including avohilmo

485

2283

2.35

57.64

3.8

4.8

241.02

239.20

u/l

0.08

463

2183

Dermatitis due to substances taken internally

480

2268

2.40

57.60

6.4

4.3

245.53

243.69

u/l

0.10

452

2152

Injuries to the knee and lower leg

9091

41156

1.22

57.54

3.8

4.5

235.85

242.96

u/l

4.95

8647

39129

Malignant neoplasm of oral cavity, including Hilmo

361

1510

2.73

57.40

4.6

2.5

228.68

231.21

u/l

0.09

349

1416

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2340

16757

1.46

57.19

3.9

4.6

238.53

242.97

u/l

0.77

2194

15907

Paracetamol or NSAID medication

1152

3442

1.76

57.12

4.4

4.8

248.78

255.65

u/l

0.50

1097

3328

Complications of cardiac and vascular prosthetic devices, implants and grafts

258

941

3.54

57.05

7.8

4.0

258.80

253.66

u/l

0.17

253

889

Other abnormalities of plasma proteins

206

664

4.17

56.75

6.7

4.4

233.74

258.62

u/l

1.02

200

632

Diabetes mellitus in pregnancy

1548

6362

1.60

56.59

3.4

4.1

222.12

227.81

u/l

0.92

1490

6088

Urticaria

2005

13971

1.50

56.42

5.2

4.5

240.08

239.34

u/l

0.07

1905

13303

Other diseases of lip and oral mucosa

3104

23302

1.38

56.32

4.9

4.6

235.34

242.82

u/l

1.88

2938

22173

Sequelae of cerebrovascular disease

3126

20071

1.39

56.28

4.2

4.4

241.73

247.71

u/l

1.78

2918

18979

Other diseases of pancreas

754

4218

2.00

56.23

4.6

4.5

243.65

245.37

u/l

0.10

715

4002

Melanocytic naevi

2212

15724

1.47

56.22

6.1

4.3

235.50

239.75

u/l

0.58

2131

14937

Disorders of oesophagus in diseases classified elsewhere

256

936

3.50

56.12

5.2

4.7

255.29

251.48

u/l

0.12

243

890

Melanocytic naevi of trunk

953

5666

1.82

55.94

6.2

4.5

238.76

240.34

u/l

0.08

918

5385

Giant cell arteritis

441

2072

2.54

55.91

3.4

4.1

236.90

249.04

u/l

0.74

411

1951

Papulosquamous disorders

2949

22016

1.40

55.79

3.9

4.6

236.26

244.10

u/l

2.33

2790

20941

Selective serotonin reuptake inhibitors

7558

32426

1.24

55.46

3.7

4.7

234.88

245.25

u/l

6.14

7104

30969

Injuries to the shoulder and upper arm

6620

41903

1.25

55.30

4.1

4.5

236.24

243.92

u/l

5.24

6233

39871

Invasive ventilation

642

3438

2.09

54.83

3.9

4.5

257.99

250.39

u/l

0.49

617

3271

Superficial injury of head

1883

13062

1.51

54.79

3.2

4.5

234.34

245.79

u/l

3.57

1761

12363

Viral hepatitis, including avohilmo

555

2802

2.17

54.78

3.9

4.8

238.91

238.81

u/l

0.01

529

2676

Drug-induced adrenocortical insufficiency

211

700

3.86

54.51

5.5

4.5

278.10

251.19

u/l

0.44

203

670

Intestinal malabsorption

419

1923

2.50

54.50

3.3

4.5

214.93

247.75

u/l

5.87

406

1824

Delirium, not induced by alcohol and other psychoactive substances

1175

7445

1.72

54.39

3.1

4.1

244.03

248.24

u/l

0.54

1083

7036

Serous carcinoma of ovary, including Hilmo

261

956

3.18

54.39

6.0

2.6

261.28

228.66

u/l

2.50

255

890

Morphin

257

949

3.33

54.29

3.6

3.9

240.68

254.17

u/l

0.53

248

900

Diseases of the ear and mastoid process

8476

35480

1.22

54.25

4.4

237.31

242.39

u/l

2.12

8011

33864

Viral hepatitis

531

2653

2.20

54.05

3.8

4.8

237.17

239.29

u/l

0.11

506

2534

Disorders of continuity of bone

742

4140

1.94

54.01

4.6

4.7

238.00

243.13

u/l

0.56

699

3949

Early onset COPD

1728

11883

1.55

53.98

3.9

4.9

240.26

244.83

u/l

0.52

1637

11313

Pyogenic arthritis

576

2985

2.15

53.66

3.8

4.9

241.99

244.09

u/l

0.12

551

2844

Migraine

3223

18903

1.36

53.35

4.1

4.7

229.15

239.54

u/l

3.63

3062

18093

Amputation of foot

315

1318

3.02

53.31

3.3

4.2

240.54

248.26

u/l

0.62

302

1248

Acidosis

245

897

3.44

53.25

3.4

4.9

253.08

244.96

u/l

0.19

233

859

Diabetic retinopathy, strict definition

1449

8598

1.63

52.96

3.5

4.0

238.41

237.16

u/l

0.18

1378

8140

Disorders of muscles

809

4667

1.88

52.76

4.1

4.9

245.58

241.75

u/l

0.35

772

4440

Pneumonia derived septicemia

342

1468

2.75

52.68

6.0

4.4

250.65

252.41

u/l

0.06

328

1386

Other symptoms and signs involving the nervous and musculoskeletal systems

3069

23220

1.37

52.61

3.9

4.5

237.52

243.47

u/l

1.10

2919

22046

Herpesviral [herpes simplex] infections, including avohilmo

1708

11707

1.52

52.52

5.4

4.4

236.23

238.33

u/l

0.27

1643

11126

Acute generalized exanthematous pustulosis

404

1857

2.50

52.50

7.0

4.3

240.10

245.98

u/l

0.39

381

1764

Fracture of femur

2341

15349

1.44

52.25

3.7

4.0

244.88

249.46

u/l

0.66

2177

14411

Mental and behavioural disorders due to opioids

287

1121

2.89

52.08

2.5

4.9

226.92

231.42

u/l

0.20

272

1074

Somatoform disorder

1132

7129

1.68

52.08

3.6

4.5

228.18

241.51

u/l

2.76

1043

6795

Non-selective monoamine reuptake inhibitors

2730

19498

1.40

52.03

3.3

4.8

235.24

248.10

u/l

4.49

2545

18567

Viral warts

737

4153

1.92

51.99

5.5

4.4

232.23

242.10

u/l

1.40

711

3942

Lupus nephritis

12.68

51.90

3.9

4.4

232.56

236.02

u/l

0.09

Cholecystectomy

5348

36793

1.27

51.50

4.4

4.3

238.53

243.37

u/l

1.43

5095

34878

Follow-up examination after treatment for malignant neoplasms

801

4643

1.87

51.36

4.6

3.9

239.65

253.09

u/l

1.41

764

4400

Duodenal ulcer

937

5691

1.79

51.35

3.4

4.5

240.17

249.28

u/l

0.80

883

5396

Other symptoms and signs involving the circulatory and respiratory systems

533

2720

2.16

51.26

3.6

4.4

245.64

243.88

u/l

0.08

497

2575

Conductive and sensorineural hearing loss

6170

33591

1.25

51.13

4.3

4.5

242.10

244.87

u/l

0.79

5782

31954

6-mercaptopurine

265

1004

2.97

50.94

7.8

4.3

252.42

234.29

u/l

0.52

260

954

Ulcerative colitis, NAS

992

6100

1.74

50.59

4.2

4.7

223.95

239.75

u/l

4.21

944

5809

Crohn's disease of small intestine

524

2671

2.16

50.59

3.9

4.6

219.49

241.37

u/l

3.12

507

2558

Myositis

270

1062

3.08

50.45

3.8

4.8

270.16

244.89

u/l

2.22

261

1012

Tumor necrosis factor alpha inhibitors

1045

6500

1.70

50.35

2.8

4.8

224.06

237.92

u/l

3.89

1001

6202

Vasculitis limited to skin, not elsewhere classified

272

1076

3.07

50.31

4.4

4.2

244.65

253.36

u/l

0.35

264

1016

Wegener granulomatosis

182

583

4.10

50.24

3.5

4.7

249.34

251.93

u/l

0.07

175

556

Other Crohn's disease

507

2557

2.17

50.24

3.8

4.7

224.04

240.38

u/l

1.70

489

2442

Pneumothorax

604

3262

2.06

50.07

4.4

4.3

244.13

243.30

u/l

0.05

581

3080

Lumbar disc prolapse

4657

27527

1.29

49.95

4.1

4.7

238.57

244.21

u/l

1.42

4433

26298

Other and unspecified disorders of skin and subcutaneous tissue

536

2788

2.15

49.79

5.2

4.2

238.32

248.27

u/l

0.65

490

2638

Generalized skin eruption due to drugs and medicaments

357

1595

2.59

49.79

7.2

4.3

240.76

248.79

u/l

0.50

336

1516

Haemorrhoids and perianal venous thrombosis

2558

18860

1.40

49.75

4.3

4.4

232.24

248.58

u/l

8.17

2401

17882

Benign neoplasm: Sigmoid colon

1571

10808

1.55

49.63

4.3

4.6

234.63

246.02

u/l

1.98

1498

10248

Glucagon-like peptide-1 (GLP-1) analogues

2186

15860

1.44

49.55

3.5

5.1

226.15

245.62

u/l

9.69

2059

15219

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2186

15860

1.44

49.55

3.5

5.1

226.15

245.62

u/l

9.69

2059

15219

Adverse effects, not elsewhere classified

1332

8798

1.59

49.52

4.1

4.6

226.79

241.21

u/l

4.05

1266

8363

IBD patients in KELA-register

1526

10362

1.54

49.38

3.8

4.8

222.66

238.02

u/l

5.97

1465

9896

Sensorineural hearing loss

5943

32502

1.25

49.25

4.2

4.5

242.86

245.33

u/l

0.64

5554

30909

Chronic viral hepatitis

376

1709

2.44

48.85

3.5

4.8

234.06

231.46

u/l

0.12

356

1630

Other diseases of upper respiratory tract

8442

37142

1.21

48.50

4.3

4.4

238.64

244.63

u/l

2.53

7991

35312

Other and unspecified vasculitis limited to skin

247

950

3.18

48.38

4.5

4.2

246.08

256.87

u/l

0.41

241

895

Malignant neoplasm of endocrine gland

441

2132

2.24

48.38

5.7

2.5

235.55

228.31

u/l

0.76

421

1993

Carcinoma in situ of skin of other and unspecified parts of face

838

5069

1.85

48.32

5.5

3.9

260.91

248.64

u/l

0.95

803

4750

Meniscus derangement

3973

20699

1.31

48.24

4.1

4.8

240.24

246.23

u/l

1.69

3781

19711

Diseases of male genital organs

3915

15376

1.32

48.12

4.4

5.1

236.99

247.91

u/l

3.75

3741

14712

Other problems related to primary support group, including family circumstances

694

3796

1.89

48.06

5.9

4.5

249.25

240.27

u/l

0.52

672

3634

Vascular diseases of the intestine

393

1862

2.46

48.02

4.3

4.1

253.48

248.60

u/l

0.18

372

1765

Vitamin deficiency

418

2016

2.34

47.74

3.3

4.4

254.29

248.59

u/l

0.14

406

1924

Vitamin deficiency, wide

418

2016

2.34

47.74

3.3

4.4

254.29

248.59

u/l

0.14

406

1924

Polycystic ovarian syndrome, consortium definition

4425

20124

1.29

47.66

3.8

4.1

233.78

239.54

u/l

2.02

4169

19104

Iron deficiency

247

940

2.97

47.29

3.7

4.5

209.46

247.83

u/l

2.99

226

892

Migraine with aura

1511

10301

1.52

47.07

3.9

4.5

232.67

237.84

u/l

0.66

1438

9853

Type of accident

2133

15551

1.43

46.94

4.0

4.5

240.12

242.36

u/l

0.29

1999

14753

Malignant neoplasm of oral cavity

281

1153

2.80

46.83

4.7

2.1

226.51

230.69

u/l

0.12

272

1082

Psoriasis

2044

14815

1.44

46.78

3.8

4.7

237.83

242.61

u/l

0.72

1937

14074

Fracture of shoulder and upper arm

2741

20745

1.37

46.73

4.1

4.5

235.71

246.04

u/l

4.06

2576

19652

Portal vein thrombosis

193

669

3.72

46.61

6.2

4.8

280.24

253.31

u/l

0.67

187

635

Hyperhidrosis

236

882

3.00

46.50

3.7

212.95

234.84

u/l

3.03

220

836

Recurrent or chronic depression

2599

13418

1.38

46.31

3.8

5.4

225.47

245.40

u/l

10.60

2450

12943

Postmenopausal osteoporosis with pathological fracture

568

3098

2.06

46.26

4.0

249.70

251.14

u/l

0.08

532

2890

Benign neoplasm: Rectum, anus and anal canal

1644

11562

1.51

46.09

4.4

4.5

238.30

246.16

u/l

1.48

1553

10948

Benign neoplasm: Transverse colon

946

5953

1.74

45.97

4.0

4.6

233.76

245.00

u/l

1.97

903

5651

Special screening examination for other diseases and disorders

822

4926

1.77

45.57

4.0

4.2

236.28

247.37

u/l

1.31

799

4702

Personality disorders

1633

11391

1.49

45.52

3.2

4.7

224.01

234.08

u/l

2.58

1538

10904

Malignant neoplasm of other and ill-defined sites, including Hilmo

157

479

4.00

45.41

5.0

1.9

266.26

236.67

u/l

1.73

151

445

Operations for atrial fibrillation

195

703

3.82

45.39

3.2

4.7

271.46

248.96

u/l

0.91

188

668

Other disorders of bone

1305

8743

1.57

45.37

4.9

4.7

231.18

240.59

u/l

2.26

1242

8325

Psoriatic and enteropathic arthropathies

802

4810

1.78

45.02

3.2

5.0

239.80

240.15

u/l

0.02

761

4583

Cardiac murmurs and other cardiac sounds

644

3582

1.90

44.88

4.5

4.7

238.89

247.79

u/l

0.84

612

3422

Exposure to other specified factors

5855

41639

1.23

44.85

4.1

4.6

232.55

242.20

u/l

6.25

5531

39705

Other specified/unspecified bacterial intestinal infections

551

2995

2.04

44.81

4.6

4.5

237.12

249.53

u/l

0.88

514

2852

Barrett oesophagus

471

2449

2.20

44.72

3.4

5.0

228.22

249.91

u/l

1.69

445

2339

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

628

3554

1.95

44.71

4.9

4.3

250.77

245.95

u/l

0.22

601

3368

Malignant neoplasm of corpus uteri, including Hilmo

566

3076

1.98

44.58

4.2

2.1

252.00

237.68

u/l

1.61

536

2846

Unknown and unspecified causes of morbidity

478

2455

2.11

44.54

5.0

3.7

244.11

240.34

u/l

0.22

462

2323

Chronic sinusitis

2970

22845

1.34

44.48

4.6

235.86

243.24

u/l

1.69

2828

21789

Rheumatism, unspecified

935

5855

1.70

44.44

3.3

4.7

235.12

247.46

u/l

1.90

884

5580

Disorders of adult personality and behaviour

1709

12070

1.47

44.43

3.3

4.7

224.39

233.90

u/l

2.12

1602

11562

Primary biliary cholangitis (PBC)

207

754

3.30

44.42

3.4

4.7

243.24

249.16

u/l

0.15

198

710

Superficial injury of lower leg

1832

13129

1.45

44.39

3.4

4.6

239.61

241.63

u/l

0.21

1741

12455

Status post-ami

2130

11855

1.43

44.38

4.7

4.6

250.31

241.99

u/l

1.91

1999

11156

Spondylopathies (FG)

890

5494

1.71

44.28

2.9

4.9

227.19

238.08

u/l

1.77

837

5239

Disorders of magnesium metabolism

121

329

5.51

44.12

3.4

5.3

252.55

244.28

u/l

0.21

115

314

Donors of organs and tissues

143

418

4.16

44.01

17.7

4.7

214.53

229.56

u/l

1.19

138

401

Inflammatory bowel disease, strict (require KELA)

1526

10609

1.50

43.83

3.8

4.8

222.66

237.94

u/l

5.99

1465

10127

Pneumococcal septicemia

321

1455

2.58

43.74

5.9

4.2

246.93

253.06

u/l

0.25

307

1377

Respiratory conditions due to other external agents

228

893

3.19

43.72

5.0

4.2

246.18

253.07

u/l

0.24

219

847

Injuries to unspecified part of trunk, limb or body region

813

4961

1.77

43.61

4.9

4.4

245.11

243.78

u/l

0.08

767

4707

Crohn's disease NAS

479

2494

2.11

43.60

3.8

4.8

226.08

243.29

u/l

1.83

457

2386

Left bundle-branch block

559

3062

1.99

43.55

4.5

244.43

239.82

u/l

0.40

523

2886

Benign neoplasm: Rectum

1475

10294

1.53

43.36

4.5

236.07

245.75

u/l

2.01

1391

9760

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1610

11160

1.48

43.26

4.6

4.2

238.95

234.54

u/l

0.50

1534

10662

Other and unspecified urticaria

1292

8725

1.55

43.21

5.1

4.5

245.17

241.23

u/l

0.30

1229

8301

Diseases of salivary glands

2294

17134

1.39

43.20

4.1

4.5

234.11

241.96

u/l

1.95

2174

16273

Coeliac disease

858

5306

1.73

43.08

3.7

4.5

229.56

242.48

u/l

2.11

822

5048

Lung diseases due to external agents

1167

7777

1.61

43.03

3.4

4.2

246.36

245.93

u/l

0.03

1097

7330

Nonorganic sleeping disorders, excluding more controls

1300

8778

1.54

42.93

3.5

4.8

224.12

238.13

u/l

4.30

1225

8432

Cholecystitis

1135

7523

1.61

42.61

4.3

242.56

246.07

u/l

0.29

1068

7086

Suicide or other Intentional self-harm

1535

10734

1.49

42.54

3.1

4.7

233.11

237.39

u/l

0.40

1426

10259

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1004

6437

1.64

42.46

3.1

4.7

229.39

233.20

u/l

0.28

938

6138

Tubulo-interstitial nephritis, not specified as acute or chronic

510

2741

2.03

42.07

3.6

4.1

233.71

244.96

u/l

1.00

479

2575

Recurrent aphthous stomatitis , including avohilmo

1054

6883

1.63

42.02

5.9

4.4

242.06

242.82

u/l

0.05

1014

6531

Temporal arteritis

366

1788

2.41

42.01

3.3

4.0

241.92

249.30

u/l

0.31

342

1685

Malignant neoplasm of rectum, including Hilmo

784

4762

1.75

41.91

3.3

2.3

255.00

234.63

u/l

1.78

750

4398

Asthma and allergy, excluding more controls

635

3554

1.84

41.90

3.3

3.9

222.60

233.19

u/l

1.24

614

3381

Heart failure and hypertrophic cardiomyopathy

217

854

3.26

41.83

11.0

4.3

265.52

245.63

u/l

1.36

206

808

Cerebral palsy and other paralytic syndromes

824

5089

1.74

41.78

4.3

4.4

259.94

245.58

u/l

0.53

775

4820

Chronic rhinitis, nasopharyngitis and pharyngitis

2216

16528

1.39

41.73

4.0

4.7

234.99

243.39

u/l

1.41

2103

15771

Mental and behavioural disorders due to tobacco

663

3877

1.86

41.71

2.9

4.9

225.04

242.39

u/l

3.09

606

3707

Acquired absence of limb

130

380

4.64

41.66

3.2

4.2

242.25

246.44

u/l

0.11

117

356

Thyroiditis, ILD-related definition

755

4553

1.77

41.45

4.1

4.5

233.43

240.90

u/l

0.78

724

4315

Malignant neoplasm of thyroid gland, including Hilmo

430

2180

2.12

41.41

5.6

2.5

233.29

227.43

u/l

0.54

411

2036

Disorders of synovium and tendon

3773

25540

1.29

41.29

4.0

4.7

238.75

243.95

u/l

1.42

3579

24353

Smoking dependency

663

3890

1.85

41.23

2.9

4.9

225.04

242.87

u/l

3.23

606

3718

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3749

28926

1.28

41.01

4.2

4.6

234.27

244.00

u/l

4.43

3557

27619

Unspecified jaundice

442

2303

2.15

40.98

4.0

4.3

263.03

251.77

u/l

0.55

423

2182

Arterial embolism and thrombosis

507

2763

2.04

40.95

4.2

4.0

256.38

247.00

u/l

0.49

477

2606

Iridocyclitis

1605

11430

1.47

40.90

4.6

235.37

242.25

u/l

1.40

1545

10829

2626

17344

1.36

40.86

3.6

4.1

244.70

250.00

u/l

1.03

2438

16338

Infection of intervertebral disc (pyogenic)

175

626

3.69

40.58

3.6

4.6

236.62

242.56

u/l

0.34

170

595

Migraine without aura

1115

7361

1.57

40.57

3.9

4.4

221.71

234.97

u/l

2.95

1055

7059

L04AC Interleukin inhibitors

464

2448

2.07

40.49

2.9

4.8

224.56

239.57

u/l

1.66

446

2343

Benign neoplasm: Caecum

917

5906

1.69

40.40

4.2

4.4

228.59

246.18

u/l

4.48

872

5594

Deforming dorsopathies

1929

14183

1.41

39.95

3.9

4.8

242.66

245.55

u/l

0.29

1832

13529

Acute pharyngitis

923

5823

1.64

39.71

5.7

4.6

228.97

240.41

u/l

1.82

894

5598

Thyrotoxicosis, other and/or unspecified

1359

9433

1.51

39.64

5.7

4.3

233.66

242.66

u/l

1.59

1286

8932

Poor fetal growth

623

3589

1.82

39.50

3.5

3.9

223.96

225.00

u/l

0.06

601

3433

Giant cell arteritis with polymyalgia rheumatica

366

1832

2.35

39.44

3.3

4.0

241.92

247.59

u/l

0.23

342

1724

Sequelae of other external causes

460

2454

2.07

39.42

4.5

4.3

238.91

247.21

u/l

0.63

441

2333

Other renal tubulo-interstitial diseases

199

752

3.06

39.23

4.5

4.2

269.33

250.24

u/l

0.36

192

706

Presence of other devices

1903

13828

1.42

39.00

4.2

4.1

236.97

245.58

u/l

2.21

1785

13055

Small fibre neuropathy

300

1396

2.55

38.97

6.3

4.2

238.33

247.89

u/l

0.51

285

1324

Amputation of ankle bones

238

1008

2.87

38.61

3.8

4.2

248.41

249.30

u/l

0.04

225

959

Failed induction of labour

327

1532

2.29

38.54

3.4

3.8

213.97

219.65

u/l

0.68

322

1452

Mixed connective tissue disease

179

658

3.32

38.23

3.6

4.1

239.27

255.24

u/l

0.54

171

628

Inflammatory diseases of the central nervous system

618

3631

1.85

38.19

4.6

4.5

254.11

245.18

u/l

0.33

586

3455

Bipolar affective disorders

1117

7495

1.55

38.14

3.1

4.7

219.81

236.83

u/l

4.95

1038

7187

Speech therapy

1896

14062

1.41

38.04

4.6

4.4

241.99

244.23

u/l

0.20

1838

13308

Hypoparathyroidism

319

1524

2.41

38.03

4.8

4.5

249.03

248.96

u/l

0.00

291

1436

Shock, not elsewhere classified

117

336

4.55

38.03

9.0

3.4

273.95

251.76

u/l

0.54

110

316

Diseases of external ear

2626

20372

1.34

37.97

4.3

4.5

237.13

244.08

u/l

1.35

2425

19359

Maternal care for other known or suspected fetal problems

1077

4415

1.58

37.73

3.5

4.0

221.97

224.31

u/l

0.22

1033

4233

Adalimumab

641

3797

1.80

37.68

3.0

4.9

224.27

238.32

u/l

2.25

614

3624

Abscess of lung

180

676

3.35

37.56

3.7

4.7

239.59

252.60

u/l

0.50

174

643

Neuromuscular dysfunction of bladder

716

4400

1.76

37.56

3.3

4.7

222.16

245.09

u/l

5.96

669

4193

Renal cell carcinoma of kidney

257

1120

2.60

37.51

4.3

2.0

248.58

234.15

u/l

0.66

248

1037

Rash and other nonspecific skin eruption

704

4301

1.76

37.45

4.8

4.3

233.76

246.49

u/l

2.00

677

4081

Symptoms and signs involving speech and voice

2436

18756

1.35

37.41

4.4

231.82

245.04

u/l

7.06

2309

17766

Diabetic neuropathy

1003

6695

1.63

37.27

3.0

4.1

231.25

238.06

u/l

1.14

962

6332

Gonarthrosis,primary

6838

35112

1.20

37.16

4.0

4.6

241.94

245.22

u/l

0.92

6457

33366

Other symptoms and signs involving the urinary system

831

5313

1.68

37.06

4.0

4.7

223.11

244.47

u/l

5.81

800

5055

Conjunctivitis (acute, non atopic)

1896

14010

1.40

37.03

5.2

4.6

232.57

240.80

u/l

1.73

1813

13354

Fracture of lower leg, including ankle

3945

31532

1.26

36.96

3.8

4.7

237.42

244.17

u/l

2.52

3755

29983

Diabetic maculopathy

1020

6468

1.62

36.95

3.4

4.1

238.46

236.84

u/l

0.19

982

6120

Specific personality disorders

1375

9675

1.47

36.67

3.3

4.6

221.46

234.23

u/l

3.67

1292

9260

Malnutrition

219

911

2.89

36.62

3.8

4.6

258.58

252.35

u/l

0.23

200

862

Migraine with aura and triptan purchases

898

5795

1.62

36.60

3.8

4.4

223.40

233.42

u/l

1.12

845

5530

Special screening examination for infectious and parasitic diseases

1261

6283

1.50

36.57

3.7

4.2

221.55

242.76

u/l

6.84

1186

6036

Late syphilis, including avohilmo

179

678

3.28

36.56

3.2

4.5

232.05

242.31

u/l

0.52

169

650

Primary hyperparathyroidism

832

5343

1.68

36.49

4.3

229.92

249.25

u/l

3.25

782

5055

Discitis, unspecified

192

756

3.16

36.49

5.7

4.5

229.05

242.64

u/l

1.15

185

713

Unspecified misadventure during surgical and medical care

481

2682

2.00

36.44

4.6

4.4

253.22

248.03

u/l

0.24

465

2549

Injuries to the elbow and forearm

5078

36299

1.22

36.37

4.1

4.5

235.29

242.29

u/l

3.75

4789

34529

Hyperplasia of prostate

2946

13016

1.32

36.26

4.5

4.9

237.66

247.61

u/l

2.99

2799

12436

Complications following infusion, transfusion and therapeutic injection

154

538

3.53

36.15

7.1

4.7

241.19

263.05

u/l

0.65

145

514

Rotator cuff syndrome

4539

25759

1.24

36.05

4.0

4.7

239.31

246.10

u/l

1.90

4305

24511

Inflammatory diseases of female pelvic organs

3772

20839

1.27

35.90

3.7

4.2

232.08

239.27

u/l

1.75

3542

19818

Malignant neoplasm of corpus uteri

502

2814

1.91

35.88

4.2

2.1

251.93

238.60

u/l

1.45

473

2608

Fissure and fistula of anal and rectal regions

1625

11837

1.43

35.86

4.8

4.6

237.21

246.52

u/l

1.67

1532

11265

Malignant neoplasm of brain, including Hilmo

318

1528

2.27

35.82

4.8

2.5

248.13

231.42

u/l

1.79

307

1435

Acute gastritis

572

3352

1.85

35.81

4.2

4.6

233.39

251.35

u/l

2.60

538

3181

Malignant neoplasm of thyroid gland

383

1965

2.09

35.73

5.7

2.5

232.77

227.87

u/l

0.42

366

1837

Single delivery by caesarean section

915

3325

1.63

35.67

4.0

4.2

239.11

231.69

u/l

0.33

889

3191

Reactive arthropathies

610

3632

1.80

35.52

3.3

5.1

233.00

242.17

u/l

0.85

583

3466

Maternal care for other conditions predominantly related to pregnancy

977

6281

1.57

35.49

3.2

4.2

216.36

231.32

u/l

3.70

944

6000

Diplopia

979

6540

1.59

35.48

4.2

4.5

238.08

243.12

u/l

0.51

928

6204

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

155

545

3.40

35.42

5.1

2.0

279.56

234.72

u/l

1.52

149

509

Asthma and allergy

635

3729

1.74

35.38

3.3

4.1

222.60

235.02

u/l

1.62

614

3549

COPD, hospital admissions 1, only main diagnosis

2806

19043

1.32

35.23

3.4

4.3

238.86

248.81

u/l

2.96

2643

17998

Bronchiectasis

653

4003

1.79

35.18

4.6

4.5

232.40

251.06

u/l

3.12

623

3770

Other follicular disorders

517

2952

1.89

34.95

4.4

4.5

224.92

240.28

u/l

1.72

484

2817

Other noninfective disorders of lymphatic vessels and lymph nodes

298

1428

2.35

34.75

5.0

4.0

250.53

245.70

u/l

0.20

282

1353

Other nutritional anaemias

121

378

4.14

34.63

6.0

4.2

323.77

239.84

u/l

0.90

110

358

Lichen simplex chronicus and prurigo

498

2840

1.92

34.55

3.4

4.4

237.85

246.74

u/l

0.70

478

2693

Focal epilepsy

1510

10957

1.44

34.53

4.5

4.6

250.45

242.45

u/l

0.58

1423

10397

Injuries to the ankle and foot

4882

34807

1.22

34.41

4.3

4.6

234.11

240.98

u/l

2.64

4650

33222

Chronic Coagulation defects

191

758

2.90

34.26

3.4

4.8

222.72

250.08

u/l

1.16

180

722

Tobacco use

412

2224

2.04

34.07

3.1

4.6

225.40

244.09

u/l

1.43

397

2125

Pneumonia due to Streptococcus pneumoniae

319

1574

2.24

34.04

6.5

4.0

237.30

242.01

u/l

0.26

304

1490

Alcohol dependence

1921

14503

1.38

34.04

2.8

5.0

233.41

242.96

u/l

1.93

1807

13868

Crohn's disease of large intestine

363

1873

2.12

34.03

3.3

4.8

224.37

241.55

u/l

1.47

347

1794

Excessive, frequent and irregular menstruation

2279

9242

1.35

33.95

3.9

4.0

232.24

242.81

u/l

1.66

2151

8752

Malignant neoplasm of oesophagus, including Hilmo

276

1295

2.39

33.82

3.0

2.2

232.97

233.98

u/l

0.03

263

1208

Pain in thoracic spine

1028

6972

1.55

33.80

3.9

4.7

229.10

243.55

u/l

3.95

970

6643

Use of pramipexole

1624

11997

1.42

33.74

3.8

4.4

239.39

245.53

u/l

1.08

1498

11340

Mucosal proctocolitis

832

5403

1.63

33.74

4.0

4.9

220.55

237.88

u/l

4.33

801

5156

Crohn disease (strict definition, require KELA, min 2 HDR)

433

2371

1.98

33.72

3.7

4.9

217.47

240.12

u/l

2.74

419

2272

Reactive arthropathies, FINNGEN

483

2736

1.90

33.60

3.4

4.9

231.03

240.03

u/l

0.63

462

2605

Supervision of high-risk pregnancy

899

3479

1.60

33.52

3.8

4.1

225.66

228.63

u/l

0.16

861

3322

Panic disorder

845

5490

1.60

33.48

3.6

4.5

219.99

235.18

u/l

3.08

782

5247

Right hemicolectomy

501

2911

1.91

33.26

4.1

241.51

248.41

u/l

0.46

480

2748

Other diseases of oesophagus

730

4645

1.69

33.10

3.6

4.5

238.98

249.50

u/l

1.11

688

4410

Injury of unspecified body region

592

3582

1.79

33.05

5.0

4.3

246.56

246.69

u/l

0.01

561

3400

Retinal detachments and breaks

2732

21709

1.30

32.99

4.6

4.5

243.40

246.29

u/l

0.55

2579

20596

Malignant neoplasm of rectum

629

3846

1.74

32.93

3.3

2.3

253.94

235.22

u/l

1.27

604

3559

Cervicalgia

1446

10493

1.44

32.89

3.6

4.7

233.40

245.20

u/l

2.92

1360

9970

Drug-induced osteoporosis

146

527

3.51

32.84

5.8

4.7

268.10

259.98

u/l

0.15

136

497

Infections with a predominantly sexual mode of transmission

1684

12444

1.39

32.81

4.3

4.4

226.12

232.79

u/l

1.50

1586

11901

Crohn disease (strict definition, require KELA)

436

2414

1.95

32.77

3.7

4.9

217.39

239.85

u/l

2.76

422

2315

Seborrhoeic keratosis

1893

14363

1.38

32.76

5.2

4.4

238.30

246.95

u/l

1.36

1818

13598

Gingival hyperplasia

309

1542

2.27

32.70

6.2

4.7

247.34

248.56

u/l

0.04

300

1475

Postviral fatigue syndrome

195

5.11

32.68

2.5

4.2

188.71

235.64

u/l

4.07

195

Disorders of vitreous body and globe

3881

30263

1.25

32.64

4.5

242.59

245.05

u/l

0.37

3702

28730

Postprocedural disorders of digestive system, not elsewhere classified

286

1389

2.35

32.59

3.8

4.4

237.38

253.50

u/l

0.92

274

1321

Late syphilis

150

552

3.43

32.55

3.3

4.6

235.23

244.39

u/l

0.37

142

527

Unspecified nephritic syndrome

208

891

2.76

32.51

3.7

4.6

239.34

251.34

u/l

0.46

198

848

Polyarteritis nodosa and related conditions

141

498

3.48

32.46

4.1

4.7

238.25

258.78

u/l

0.57

134

478

Childhood asthma (age<16), excluding more controls

580

2660

1.76

32.46

3.6

3.7

215.06

224.57

u/l

1.10

553

2559

Other obstructive and reflux uropathy

306

1511

2.22

32.38

4.0

4.1

235.37

244.27

u/l

0.43

290

1423

Other congenital malformations

541

3193

1.81

32.26

5.2

4.8

235.52

245.94

u/l

0.79

528

3058

Viral warts, including avohilmo

1395

10082

1.44

32.25

5.2

4.6

232.34

239.32

u/l

1.41

1333

9599

Alcohol-induced chronic pancreatitis

504

2951

1.88

32.24

2.8

4.8

234.10

244.86

u/l

0.54

475

2824

Other disorders of bladder

955

6497

1.57

32.09

3.8

4.6

233.46

248.31

u/l

1.95

880

6180

Abscess of anal and rectal regions

579

3491

1.77

32.08

4.5

4.8

247.67

244.97

u/l

0.09

554

3346

Thyrotoxicosis

1673

12476

1.39

32.03

5.2

4.3

234.23

242.97

u/l

1.93

1585

11811

Postpartum care and examination

604

2238

1.76

32.01

3.9

3.6

224.98

221.65

u/l

0.25

580

2121

Psoriasis vulgaris

1286

9210

1.46

31.96

3.8

4.7

234.87

240.70

u/l

0.89

1218

8773

Attention to artificial openings

340

1767

2.15

31.86

3.9

4.2

232.22

243.71

u/l

0.62

320

1672

Emphysema

624

3875

1.75

31.86

3.6

4.6

252.89

248.44

u/l

0.22

595

3652

Other peripheral vascular diseases

576

3485

1.78

31.83

4.0

4.3

241.45

243.21

u/l

0.10

543

3294

Coxibs

2078

8260

1.36

31.76

3.6

4.9

229.67

252.08

u/l

11.82

1941

7928

Ovarian cyst

2059

8925

1.36

31.71

3.6

4.1

230.69

243.25

u/l

3.62

1958

8459

Retinal vascular occlusion

978

6717

1.56

31.51

4.3

4.4

246.46

247.72

u/l

0.11

922

6313

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

454

2576

1.90

31.42

3.6

4.9

218.04

239.94

u/l

2.78

439

2470

Familial hypercholesterolemia

1138

8022

1.50

31.39

3.8

4.5

244.61

247.79

u/l

0.28

1078

7580

Polyarthritis, unspecified

293

1450

2.26

31.39

4.1

4.7

235.73

247.14

u/l

0.73

285

1382

Traumatic subdural haemorrhage

1133

7459

1.50

31.26

4.4

4.7

241.55

251.75

u/l

1.58

1065

7082

Trochanteric bursitis

1014

6983

1.53

31.19

3.6

4.7

239.08

248.94

u/l

0.60

951

6640

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

412

2267

1.94

31.09

3.4

4.9

236.23

236.32

u/l

0.00

389

2178

Heartburn

767

4984

1.62

31.09

4.6

4.5

231.08

242.87

u/l

1.44

722

4728

Non-small cell lung cancer, squamous, helper endpoint

460

2657

1.92

31.05

4.4

4.0

222.86

249.68

u/l

5.14

449

2490

Superficial injury of hip and thigh

1151

8133

1.49

30.97

3.8

4.2

238.90

244.63

u/l

0.83

1089

7668

Syphilis, including avohilmo

227

1028

2.55

30.92

3.2

4.6

234.60

249.07

u/l

0.68

216

986

Syphilis

227

1028

2.55

30.92

3.2

4.6

234.60

249.07

u/l

0.68

216

986

Benign neoplasm of mouth and pharynx

795

5244

1.62

30.83

4.7

4.4

241.25

244.34

u/l

0.14

745

4970

Other encephalitis

231

1052

2.51

30.81

4.5

4.8

274.18

254.21

u/l

0.31

218

996

Carcinoma in situ of skin

722

4692

1.68

30.80

4.9

4.2

251.49

246.98

u/l

0.28

688

4422

Focal epilepsy, strict definition

1397

10209

1.43

30.75

4.6

4.5

251.87

242.80

u/l

0.64

1316

9685

Retinal vascular disorders

988

6829

1.54

30.74

4.2

4.3

246.38

247.77

u/l

0.12

930

6416

Keratitis

2449

19330

1.31

30.66

4.5

241.29

242.54

u/l

0.12

2336

18339

Type 1 diabetes, definitions combined

525

3097

1.78

30.56

4.3

5.1

231.38

239.37

u/l

0.88

516

2973

Acute and subacute iridocyclitis

1294

9351

1.45

30.45

4.7

4.6

236.80

241.56

u/l

0.67

1245

8881

Encephalitis

243

1136

2.43

30.37

4.4

4.7

282.74

251.13

u/l

0.54

228

1075

Abnormality of red blood cells

201

5.64

30.36

3.5

5.1

234.47

240.99

u/l

0.19

193

Use of anticholinesterases

1959

19481

0.75

30.26

2.9

4.0

242.06

249.96

u/l

1.38

1768

18341

N06DA Anticholinesterases

1959

19481

0.75

30.26

2.9

4.0

242.06

249.96

u/l

1.38

1768

18341

Disorders of vitreous body

3756

29597

1.24

30.23

4.5

242.44

245.09

u/l

0.39

3586

28114

Hypertrophic cardiomyopathy

361

1960

2.08

30.21

8.3

4.4

261.90

246.68

u/l

0.94

347

1865

Extreme obesity with alveolar hypoventilation

337

1783

2.12

30.20

2.6

4.8

242.87

246.26

u/l

0.12

307

1697

Ulcer of oesophagus

555

3394

1.79

30.19

3.8

4.5

240.46

249.18

u/l

0.78

524

3236

Type 1 diabetes, strict (exclude DM2)

521

3078

1.77

30.19

4.3

5.1

231.76

240.11

u/l

0.93

512

2954

Artificial joint operation, meniscal resection

6810

37709

1.18

30.17

4.0

4.6

240.34

244.61

u/l

1.59

6424

35840

Fracture of foot, except ankle

1581

11785

1.39

30.09

4.5

4.7

236.63

239.12

u/l

0.24

1495

11233

Childhood asthma (age<16)

581

2723

1.72

30.09

3.6

3.9

215.05

225.77

u/l

1.33

554

2622

Melanocytic naevi, other sites/unspecified

584

3598

1.74

30.08

6.7

4.5

231.45

240.77

u/l

0.67

572

3426

Benign neoplasm of other and unspecified endocrine glands

944

6485

1.54

29.89

4.2

4.7

230.85

243.04

u/l

2.31

890

6173

Other and unspecified tonsillitis

1883

11895

1.35

29.87

4.5

225.49

236.90

u/l

2.62

1802

11449

Psoriatic arthropathies

673

4290

1.66

29.83

3.3

5.2

243.30

244.75

u/l

0.07

636

4094

Malignant neoplasm of tongue, including Hilmo

198

853

2.64

29.81

4.4

2.1

213.72

232.45

u/l

2.66

192

804

Mental and behavioural disorders due to sedatives or hypnotics

443

2537

1.88

29.69

3.1

4.8

229.69

240.35

u/l

0.78

403

2423

Dermatophytosis

1034

7240

1.51

29.67

4.9

4.5

251.86

242.07

u/l

0.74

988

6894

Cerebral cysts

412

2318

1.93

29.61

3.7

4.4

255.79

248.94

u/l

0.21

385

2212

Other juvenile arthritis

242

1125

2.33

29.55

3.4

5.1

247.18

239.85

u/l

0.17

237

1086

Toxic liver disease

145

546

3.18

29.50

5.7

4.9

266.95

250.68

u/l

0.54

137

520

Visual impairment including blindness (binocular or monocular)

548

3352

1.77

29.45

3.3

4.0

255.73

250.17

u/l

0.17

501

3161

Orchitis and epididymitis

734

4812

1.63

29.35

4.8

5.0

233.88

245.07

u/l

1.05

696

4575

Open wound of ankle and foot

737

4821

1.62

29.35

4.2

4.5

240.68

241.45

u/l

0.06

705

4586

Right bundle-branch block

293

1484

2.19

29.31

4.1

4.4

241.38

237.74

u/l

0.15

273

1404

Alcohol abuse, main dg, excluding more controls

974

6731

1.51

29.21

2.7

5.2

233.63

241.23

u/l

0.79

931

6466

Focal epilepsy, mode (most common among epilepsy diagnosis)

1312

9576

1.43

29.11

4.5

4.6

251.66

242.30

u/l

0.76

1238

9090

Colitis, primary sclerosing, strict definition

103

321

3.94

29.09

3.3

4.7

203.54

234.80

u/l

2.70

103

307

1845

13256

1.36

28.97

3.6

4.0

244.75

250.39

u/l

0.84

1693

12450

ILD-related respiratory insufficiency

323

1726

2.16

28.96

4.8

4.1

286.23

253.81

u/l

2.42

315

1643

Anterior Iridocyclitis

1365

10034

1.42

28.96

4.6

236.98

241.93

u/l

0.72

1314

9527

Other aneurysm

450

2632

1.88

28.95

4.4

4.2

249.37

246.19

u/l

0.19

434

2491

Adenocarcinoma and papilloma adenocarcinoma of rectum

607

3801

1.69

28.92

3.3

2.2

252.38

234.06

u/l

1.59

582

3510

Assault

774

5107

1.58

28.88

2.9

4.8

228.19

235.94

u/l

0.70

726

4897

Infective dermatitis

811

5439

1.58

28.84

3.9

4.5

237.54

243.41

u/l

0.63

767

5168

Generalized anxiety disorder

904

6141

1.52

28.73

3.6

4.4

215.32

234.09

u/l

5.07

830

5873

Oesophagitis

430

2485

1.90

28.68

3.7

4.6

230.18

249.15

u/l

2.87

408

2375

Hypopituitarism

490

2920

1.80

28.60

4.3

5.0

237.41

245.63

u/l

0.49

465

2795

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

259

4.25

28.59

8.9

2.1

265.22

228.01

u/l

1.28

246

Menorrhagia

1992

8505

1.34

28.52

3.8

4.1

234.92

245.46

u/l

1.34

1869

8046

Umbilical hernia

1932

14968

1.34

28.47

4.0

4.8

241.42

243.85

u/l

0.24

1859

14265

Bullous disorders

473

2821

1.84

28.47

3.7

4.1

239.25

248.84

u/l

0.81

448

2662

Acute suppurative otitis media

1441

9920

1.39

28.30

4.6

4.4

230.05

232.06

u/l

0.18

1364

9490

Later onset COPD

2435

15607

1.31

28.29

3.1

4.2

237.78

250.22

u/l

5.39

2293

14710

Oter anti-inflammatory and antirheumatic agents, non-steroids

1716

7095

1.38

28.27

3.7

4.9

236.38

255.42

u/l

5.60

1599

6793

Other abnormal uterine and vaginal bleeding

1425

7529

1.41

28.26

3.7

4.2

242.09

247.91

u/l

0.79

1322

7106

Post-traumatic stress disorder

454

2637

1.80

28.17

4.0

4.2

213.04

234.14

u/l

1.82

422

2538

Abnormal involuntary movements

962

6704

1.51

28.13

3.6

4.5

234.28

242.92

u/l

1.25

908

6370

Other epidermal thickening

362

2001

2.00

28.09

5.1

4.2

228.73

245.10

u/l

2.13

346

1896

Drug-induced polyneuropathy

111

380

3.92

28.07

11.6

4.3

248.07

246.60

u/l

0.04

111

365

Etanercept

425

2447

1.87

28.03

2.6

4.7

231.76

244.19

u/l

1.17

401

2333

Bacterial, viral and other infectious agents

553

3419

1.72

27.95

5.7

4.8

237.48

241.28

u/l

0.28

533

3266

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

627

3990

1.66

27.93

3.2

2.3

252.38

234.61

u/l

1.58

601

3685

Combinations of oral blood glucose lowering drugs

2102

16531

1.32

27.91

3.6

5.0

227.76

250.63

u/l

10.39

1995

15793

Special screening examination for neoplasms

454

2667

1.82

27.81

4.1

4.5

246.35

250.08

u/l

0.14

428

2531

Disorders of iron metabolism

146

567

3.03

27.81

3.9

5.1

219.43

240.29

u/l

1.77

138

548

Pain associated with micturition

839

5709

1.55

27.68

4.3

4.5

226.24

244.06

u/l

4.30

772

5430

Other ulcerative colitis

395

2241

1.91

27.58

3.4

4.7

231.70

245.15

u/l

0.98

379

2148

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

445

2612

1.83

27.41

2.7

4.4

220.58

240.00

u/l

2.54

424

2496

Acute lymphadenitis

376

2108

1.92

27.12

5.4

4.6

227.86

243.66

u/l

1.63

361

2004

Infections with a predominantly sexual mode of transmission, including avohilmo

2170

15603

1.30

27.07

4.3

224.17

232.57

u/l

2.69

2046

14927

Other disorders of eye and adnexa

930

6479

1.50

26.91

4.4

4.5

234.85

241.66

u/l

0.71

883

6155

Juvenile arthritis (FINNGEN)

261

1294

2.16

26.89

3.3

5.0

245.03

240.33

u/l

0.11

255

1244

Malignant neoplasm of brain

219

1024

2.34

26.63

4.5

2.5

241.09

232.29

u/l

0.54

211

968

Other bursopathies

928

6492

1.50

26.52

4.1

4.9

243.36

246.45

u/l

0.27

881

6168

Malignant neoplasm of renal pelvis, including Hilmo

109

373

3.53

26.37

5.4

2.0

233.73

239.76

u/l

0.33

104

347

Phobic anxiety disorders

700

4588

1.58

26.33

3.5

4.7

219.84

234.28

u/l

2.99

668

4391

Paralytic ileus

305

1632

2.07

26.25

4.0

4.3

239.86

259.53

u/l

1.07

285

1558

Carcinoma in situ of skin of trunk

323

1785

2.08

26.24

5.4

4.0

238.42

248.67

u/l

0.71

313

1685

Drug-induced systemic lupus erythematosus

221

4.73

26.18

3.8

4.7

251.19

242.73

u/l

0.28

214

Personal history of medical treatment

113

400

3.48

26.05

4.1

5.1

238.07

235.80

u/l

0.10

108

381

Neuroendocrine tumor and carcinoma of small intestine

120

436

3.26

25.95

3.7

2.0

234.08

235.12

u/l

0.04

113

410

Other congenital malformations, including avohilmo

769

5195

1.55

25.83

5.0

4.7

235.40

243.32

u/l

0.72

746

4961

Other shoulder lesions

631

4100

1.62

25.74

3.8

4.9

224.97

243.64

u/l

5.06

587

3905

Mixed and other personality disorders

463

2788

1.76

25.69

3.0

4.9

221.95

237.21

u/l

1.48

433

2673

Malignant neoplasm of pancreas, including Hilmo

534

3339

1.69

25.68

4.0

2.2

252.37

234.92

u/l

1.39

514

3089

Disorders of vestibular function (Vertigo)

3395

27562

1.23

25.64

4.0

4.4

235.43

245.41

u/l

5.26

3180

26120

Bacterial, viral and other infectious agents, including avohilmo

578

3687

1.66

25.63

5.7

4.7

237.23

241.66

u/l

0.35

558

3521

Pregnancy examination and test

643

2532

1.62

25.62

3.3

3.8

219.10

222.90

u/l

0.29

626

2404

Thiazolidinediones

858

5984

1.53

25.58

3.0

4.9

235.64

250.12

u/l

1.81

804

5695

Other condition

956

6765

1.48

25.49

4.4

4.6

239.02

241.00

u/l

0.17

917

6426

Vitamin D deficiency

153

633

2.76

25.29

2.6

4.8

234.23

238.76

u/l

0.18

148

606

Other benign neoplasms of skin

2661

21705

1.26

25.26

4.8

4.3

240.30

244.65

u/l

0.75

2500

20538

Other arterial embolism and thrombosis

243

1224

2.25

25.22

3.6

4.1

243.64

252.68

u/l

0.47

233

1162

Internal derangement of knee

2434

19439

1.27

25.00

4.0

4.9

232.14

245.24

u/l

5.70

2288

18529

Leisure time condition

1238

9177

1.41

24.96

3.6

4.6

240.48

241.70

u/l

0.10

1139

8704

Persistent mood disorders

1210

8950

1.40

24.45

3.7

4.6

229.07

242.86

u/l

2.92

1128

8483

Cervical disc disorders

2467

20017

1.27

24.43

4.1

4.8

232.91

245.72

u/l

7.15

2315

19116

Atopic dermatitis, strict definition with reimbursement

1643

12151

1.33

24.39

4.2

4.4

236.70

235.69

u/l

0.06

1573

11630

Irregular menses

2555

15518

1.26

24.32

3.9

4.2

225.41

236.73

u/l

4.91

2426

14798

Corns and callosities

482

2997

1.73

24.31

4.5

4.3

243.54

247.95

u/l

0.17

456

2836

Prurigo nodularis

217

1067

2.33

24.29

2.9

4.3

241.46

253.75

u/l

0.43

209

1019

Other extrapyramidal and movement disorders in other diseases

1767

13839

1.32

24.18

3.4

4.5

237.76

245.95

u/l

1.46

1646

13108

Amenorrhoea

358

2033

1.85

24.18

4.6

4.1

231.74

237.01

u/l

0.30

344

1937

Malignant neoplasm of tongue

149

622

2.73

24.17

4.4

2.2

212.02

233.71

u/l

2.36

143

589

Ankylosing spondylitis

576

3724

1.64

24.16

3.1

4.9

231.79

241.05

u/l

0.92

539

3559

Otitis externa

1514

11602

1.35

24.15

4.3

4.6

237.42

240.67

u/l

0.28

1422

11020

Other blood glucose lowering drugs, excl. Insulins

1158

8566

1.42

24.14

3.0

4.7

233.34

251.10

u/l

4.19

1092

8118

Voice disturbances

1802

14140

1.32

24.08

4.1

4.5

231.04

244.64

u/l

6.33

1721

13403

Disease of hard tissues of teeth, NOS

3817

16768

1.22

24.08

4.4

4.1

230.24

252.00

u/l

16.52

3613

15921

Acetic acid derivatives and related substances

2015

8164

1.31

24.00

3.9

4.9

235.85

251.83

u/l

2.82

1899

7835

Carpal tunnel syndrome

4245

31370

1.20

23.92

3.8

4.6

238.88

243.32

u/l

1.21

4018

29834

Laparoscopic right hemicolectomy

482

3036

1.75

23.90

3.5

4.2

220.56

248.37

u/l

6.79

460

2869

Coxarthrosis, primary

4621

32995

1.19

23.81

3.9

4.5

240.30

246.71

u/l

2.77

4356

31253

Abnormal findings on diagnostic imaging of central nervous system

343

1954

1.90

23.75

5.7

4.3

234.72

243.44

u/l

0.55

322

1857

Postzoster neuralgia

157

686

2.71

23.73

7.0

4.0

260.37

245.89

u/l

0.53

151

646

Other surgical follow-up care

234

1176

2.17

23.72

4.4

4.1

242.75

232.73

u/l

0.36

229

1115

Abnormal findings on antenatal screening of mother

368

2113

1.82

23.70

2.9

3.8

208.70

219.48

u/l

1.29

348

2011

Alcohol-induced acute pancreatitis

286

1555

2.05

23.68

3.0

4.8

213.68

242.91

u/l

6.70

265

1490

Urolithiasis

2385

19389

1.27

23.65

4.3

4.5

236.75

244.92

u/l

1.39

2258

18419

Other and unspecified erythematous conditions

252

1312

2.14

23.65

4.4

4.6

240.50

248.07

u/l

0.31

238

1254

Artrosis, including avohilmo

5821

27711

1.17

23.57

4.0

4.8

237.26

244.88

u/l

3.53

5484

26442

Allergic purpura

212

1034

2.27

23.52

3.7

4.2

231.42

249.85

u/l

1.15

203

985

Inguinal hernia

4275

24215

1.20

23.48

4.4

4.7

241.37

245.74

u/l

0.97

4072

23009

Exfoliative dermatitis

115

438

3.24

23.39

5.7

4.6

258.99

243.51

u/l

0.54

110

417

Carcinoma in situ of skin of upper limb, including shoulder

260

1397

2.18

23.38

5.2

4.0

254.20

246.61

u/l

0.36

249

1324

Nonorganic sleeping disorders

1300

9780

1.37

23.35

3.5

4.6

224.12

238.43

u/l

4.37

1225

9310

Suppurative and unspecified otitis media

2080

14681

1.28

23.24

4.7

4.4

230.75

234.99

u/l

0.51

1971

14024

Benign thyroid growths and nodules

2167

16186

1.28

23.20

4.3

4.2

239.59

244.90

u/l

1.02

2049

15265

Diseases of inner ear

3929

32007

1.20

23.16

4.1

4.4

236.76

244.88

u/l

4.06

3682

30387

Impetigo

291

1584

1.98

23.13

5.4

5.2

243.99

250.95

u/l

0.17

278

1516

Hidradenitis suppurativa

233

1177

2.14

23.11

2.7

4.6

209.48

238.71

u/l

3.34

217

1129

Colon adenocarcinoma, helper endpoint

1005

7339

1.45

23.08

3.1

4.3

239.49

246.39

u/l

0.82

955

6917

Varicose veins

4302

27794

1.19

23.05

4.3

247.34

244.36

u/l

0.59

4052

26327

Moderate visual impairment, binocular

257

1362

2.11

23.00

3.1

3.7

234.64

261.42

u/l

1.97

228

1296

Oxicams

1722

7584

1.33

22.94

3.8

4.9

241.19

254.15

u/l

2.57

1617

7273

Chronic laryngitis and laryngotracheitis

967

6996

1.45

22.89

3.7

4.7

237.03

243.45

u/l

0.73

883

6644

Cyst of kidney

565

3715

1.64

22.86

4.5

4.4

233.81

246.11

u/l

1.37

542

3518

Appendectomy

4145

33710

1.19

22.84

4.4

4.5

234.73

240.46

u/l

1.91

3946

32149

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

218

1079

2.18

22.81

5.3

4.8

236.00

253.36

u/l

1.16

212

1030

Secondary malignant neoplasm of respiratory and digestive organs

142

598

2.73

22.78

2.8

2.1

273.79

237.99

u/l

1.48

135

562

Neuralgia and neuritis, unspecified

362

2120

1.84

22.78

3.9

4.8

245.83

244.21

u/l

0.04

339

2019

Calculus of kidney and ureter

2179

17621

1.28

22.73

4.3

4.5

236.96

244.11

u/l

1.02

2060

16734

Inflammatory disease of uterus

728

4984

1.52

22.71

3.5

4.2

233.05

235.65

u/l

0.10

691

4735

Total colectomy

298

1659

1.97

22.56

4.9

4.5

222.02

249.26

u/l

2.51

286

1588

Total colectomy operation

298

1659

1.97

22.56

4.9

4.5

222.02

249.26

u/l

2.51

286

1588

Benign neoplasm: Small intestine

333

1934

1.92

22.53

4.3

4.1

232.30

247.91

u/l

1.56

310

1841

Speech disturbances, not elsewhere classified

683

4671

1.56

22.50

5.1

4.3

232.52

247.79

u/l

2.23

634

4403

Carcinoma in situ of skin of scalp and neck

282

1575

2.08

22.48

6.0

4.1

240.53

247.19

u/l

0.48

272

1476

Other hammer toe(s) (acquired)

1162

7875

1.40

22.45

3.5

4.7

247.78

249.68

u/l

0.12

1082

7453

Speech and linguistic disorders, excluding more controls

444

2555

1.70

22.42

5.3

4.7

243.15

248.22

u/l

0.28

427

2454

Other disorders of eyelid

3330

26476

1.22

22.38

4.3

240.76

247.03

u/l

1.57

3170

25043

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

153

669

2.58

22.37

3.4

2.1

209.69

233.75

u/l

4.17

147

633

Volvulus

221

1120

2.20

22.36

4.2

4.4

239.20

253.11

u/l

0.60

210

1072

Other erythematous conditions

272

1479

2.03

22.36

4.3

4.5

240.91

245.92

u/l

0.21

258

1413

Nummular dermatitis

619

4154

1.59

22.35

4.5

4.4

233.26

244.05

u/l

1.27

584

3945

Other and unspecified visual disturbances

723

4993

1.53

22.29

4.9

4.4

230.16

243.38

u/l

2.83

680

4739

Benign neoplasm: Descending colon

558

3685

1.64

22.20

4.1

4.5

233.02

247.25

u/l

1.71

531

3499

Open wound of forearm

671

4571

1.55

22.15

3.9

4.3

230.41

243.24

u/l

2.24

620

4338

Congenital malformations of cardiac septa

418

2474

1.74

22.15

4.3

5.1

276.12

254.96

u/l

1.04

401

2369

Other specified disorders of kidney and ureter

256

1373

2.08

22.13

5.3

4.6

261.79

251.56

u/l

0.36

244

1310

Pneumonitis due to solids and liquids

648

4400

1.57

22.13

2.9

4.0

247.76

248.33

u/l

0.02

605

4144

Gestational diabetes (for exclusion)

1604

8514

1.32

22.13

3.3

4.1

221.49

227.58

u/l

1.12

1540

8151

Malignant neoplasm of bone and articular cartilage of limbs

119

5.76

22.04

8.5

2.5

252.86

226.67

u/l

0.90

114

Faecal incontinence

624

4194

1.57

22.02

3.2

4.2

256.03

251.54

u/l

0.19

590

3960

Other disorders of nervous system

497

3195

1.67

22.00

4.1

4.4

238.82

246.13

u/l

0.54

472

3031

Benign neoplasm: Adrenal gland

571

3789

1.62

21.96

4.0

4.6

235.04

246.93

u/l

1.26

538

3597

Superficial injury of wrist and hand

1276

9665

1.36

21.90

3.6

4.8

232.43

238.92

u/l

0.66

1206

9231

Fracture of skull and facial bones

1410

10843

1.34

21.89

4.1

4.8

234.71

241.63

u/l

1.32

1331

10315

Migraine without aura and triptan purchases

828

5840

1.46

21.85

3.6

4.4

217.47

232.72

u/l

3.27

784

5573

Neovascular glaucoma

323

1865

1.90

21.84

4.2

4.3

250.00

248.51

u/l

0.06

312

1768

Sulfonylureas

2662

17486

1.25

21.84

2.9

4.5

234.62

253.20

u/l

9.48

2501

16523

Other inflammation of eyelid

981

7178

1.43

21.70

5.0

4.5

228.45

245.28

u/l

5.50

925

6805

Disorders of porphyrin and bilirubin metabolism

105

393

3.18

21.66

4.8

5.4

214.22

255.53

u/l

2.86

382

Any prescribed medicine buy

13.61

21.61

4.3

2.4

241.97

229.54

u/l

0.23

Erythema nodosum

214

1084

2.19

21.60

5.5

4.2

251.46

247.56

u/l

0.10

204

1031

Diseases of middle ear and mastoid

3633

25162

1.20

21.53

4.8

4.4

234.01

239.54

u/l

1.35

3451

23958

Emotionally unstable personality disorder

631

4243

1.54

21.52

2.9

4.7

217.47

231.28

u/l

1.99

585

4066

Glaucoma secondary to other eye disorders

326

1896

1.89

21.51

4.2

4.4

249.78

249.26

u/l

0.02

315

1809

Synovial cyst of popliteal space [Baker]

520

3387

1.64

21.44

4.4

4.6

245.49

248.41

u/l

0.15

494

3212

Benign neoplasm: Duodenum

231

1222

2.17

21.40

4.3

4.5

230.32

248.01

u/l

1.77

214

1168

Other and unspecified rosacea

590

3943

1.58

21.40

4.8

4.5

247.32

244.41

u/l

0.16

560

3741

Amputation of thigh

268

1479

2.03

21.39

3.8

3.7

262.41

256.90

u/l

0.13

248

1397

Use of donepezil

1039

13232

0.72

21.37

2.7

3.8

240.83

251.69

u/l

1.46

936

12379

Crohn disease (strict definition, all UC cases excluded)

331

1925

1.85

21.29

3.9

4.9

220.17

243.47

u/l

2.14

320

1840

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

973

7114

1.42

21.27

4.0

4.7

223.37

237.69

u/l

3.93

929

6779

Superficial injury of abdomen, lower back and pelvis

1023

7545

1.41

21.25

3.5

4.5

232.74

240.18

u/l

1.07

956

7161

Striking against or struck by other objects

2132

17250

1.26

21.21

4.1

4.8

239.94

239.83

u/l

0.01

2018

16491

Qualitative platelet defects

120

5.91

21.21

5.7

4.1

241.44

235.79

u/l

0.09

113

Olecranon bursitis

477

3065

1.68

21.19

3.7

5.3

253.74

242.58

u/l

0.44

457

2920

Ocular pain

536

3513

1.61

21.18

4.7

4.5

230.93

241.37

u/l

0.92

506

3332

Unspecified urinary incontinence

610

4122

1.57

21.13

3.2

4.3

237.31

248.53

u/l

1.26

548

3897

Spontaneous rupture of synovium and tendon

580

3879

1.59

21.12

4.4

4.9

247.32

247.07

u/l

0.01

533

3688

Melanoma in situ

375

2289

1.81

21.12

5.8

4.1

246.80

248.40

u/l

0.06

360

2164

Ulcerative colitis (strict definition, require KELA)

1005

7395

1.41

21.11

3.9

4.8

223.55

238.03

u/l

4.08

959

7048

Other disorders of the musculoskeletal system and connective tissue

1018

7534

1.41

21.11

3.9

4.5

239.11

243.39

u/l

0.55

961

7142

Dissociative [conversion] disorders

223

1145

2.09

21.02

2.6

4.3

229.08

238.61

u/l

0.22

205

1087

Arthropathic psoriasis

725

5065

1.50

20.99

3.3

4.7

244.22

242.24

u/l

0.10

687

4832

Other congenital malformations of skin

261

1422

1.99

20.97

6.7

4.7

214.67

251.60

u/l

3.89

254

1357

Maternal care for known or suspected abnormality of pelvic organs

1111

5539

1.39

20.85

3.9

4.3

230.12

230.78

u/l

0.04

1075

5297

Family history of malignant neoplasm

607

4086

1.55

20.75

4.6

4.0

229.05

236.43

u/l

0.82

579

3886

Papillary adenocarcinoma of thyroid gland

269

1475

1.94

20.75

6.2

2.5

230.51

226.95

u/l

0.22

260

1383

Carcinoma in situ of skin of ear and external auricular canal

173

846

2.47

20.54

5.2

3.9

242.66

253.82

u/l

0.56

165

799

Other and unspecified follicular disorders

289

1639

1.91

20.49

5.7

4.6

238.79

243.73

u/l

0.21

272

1555

Other disorders of optic [2nd] nerve and visual pathways

439

2783

1.69

20.47

4.3

4.5

241.01

249.49

u/l

0.51

417

2651

Testicular dysfunction

292

1665

1.91

20.43

5.2

5.1

231.42

235.74

u/l

0.16

279

1597

Fall on and from stairs and steps

1771

14152

1.29

20.36

3.8

4.5

236.83

242.52

u/l

0.94

1678

13405

Other/unspecified reactive arthropathies

430

2713

1.69

20.35

3.5

4.5

232.74

242.68

u/l

0.60

411

2585

Xerosis cutis

161

760

2.47

20.26

6.1

4.0

232.77

245.98

u/l

1.11

153

719

Assault by bodily force

432

2715

1.67

20.22

2.9

4.9

217.24

237.31

u/l

3.18

406

2598

Fracture of forearm

3707

28492

1.19

20.17

4.0

4.5

237.47

243.27

u/l

2.04

3511

27049

Other other unspecified disorders of the circulatory system

282

1605

1.94

20.17

3.4

4.5

279.56

251.11

u/l

1.75

274

1526

Testicular hypofunction

264

1469

1.97

20.10

5.3

5.1

233.80

237.18

u/l

0.11

251

1407

Disorders of conjunctiva

5664

38637

1.15

20.09

4.5

4.4

237.54

241.76

u/l

1.02

5395

36760

Deficiency of other B group vitamins

175

851

2.32

20.01

4.2

4.3

242.20

247.62

u/l

0.18

168

805

Asthma and opportunity respiratory infection

368

2263

1.78

19.99

4.3

4.5

231.58

254.46

u/l

2.46

352

2131

Transport accidents

3017

21105

1.21

19.93

4.0

4.8

233.74

245.60

u/l

5.18

2863

20229

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1071

8030

1.38

19.91

3.9

4.8

223.93

237.77

u/l

4.05

1025

7661

Drug-induced hypoglycaemia without coma

143

647

2.55

19.76

2.9

4.3

240.11

253.70

u/l

0.68

133

613

Cutaneous lupus erythematosus

185

923

2.25

19.72

3.3

4.1

240.28

247.50

u/l

0.25

176

877

Lesion of ulnar nerve

919

6761

1.42

19.64

4.0

4.8

239.27

241.53

u/l

0.09

869

6460

Pleural plaque

760

5457

1.48

19.64

3.6

4.2

237.33

248.92

u/l

1.55

717

5123

Other/unspecified synovitis and tenosynovitis

732

5179

1.48

19.61

4.0

4.8

239.04

246.25

u/l

0.75

699

4925

Hallux valgus (acquired)

2053

11896

1.26

19.56

3.8

4.7

244.15

246.53

u/l

0.30

1941

11288

Hypermobility syndrome

271

1515

1.89

19.55

3.1

4.4

211.99

236.86

u/l

2.55

258

1452

Scoliosis

521

3450

1.58

19.53

3.7

4.4

248.40

243.26

u/l

0.17

495

3281

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS